Gene Symbol | Gene ID | Gene Info |
---|---|---|
Etv1
|
ENSMUSG00000004151.10 | Etv1 |
Etv5
|
ENSMUSG00000013089.9 | Etv5 |
Gabpa
|
ENSMUSG00000008976.10 | Gabpa |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
Etv1 | chr12_38778799_38780227 | 133 | 0.968179 | 0.66 | 1.1e-08 | Click! |
Etv1 | chr12_38780373_38781378 | 27 | 0.981368 | 0.54 | 7.2e-06 | Click! |
Etv1 | chr12_38783979_38784442 | 701 | 0.727239 | 0.45 | 2.8e-04 | Click! |
Etv1 | chr12_38788429_38788940 | 5175 | 0.242947 | 0.41 | 9.9e-04 | Click! |
Etv1 | chr12_38782543_38782761 | 818 | 0.671337 | 0.40 | 1.8e-03 | Click! |
Etv5 | chr16_22438264_22439568 | 654 | 0.711589 | 0.66 | 8.6e-09 | Click! |
Etv5 | chr16_22439993_22440521 | 538 | 0.774804 | 0.49 | 8.1e-05 | Click! |
Etv5 | chr16_22437633_22437978 | 1291 | 0.452568 | 0.39 | 2.1e-03 | Click! |
Etv5 | chr16_22444642_22444937 | 5070 | 0.203315 | -0.37 | 3.6e-03 | Click! |
Etv5 | chr16_22428620_22429745 | 7332 | 0.198915 | 0.28 | 3.0e-02 | Click! |
Gabpa | chr16_84875849_84876000 | 15879 | 0.141478 | 0.28 | 3.2e-02 | Click! |
Gabpa | chr16_84875084_84875574 | 15284 | 0.142325 | 0.21 | 1.0e-01 | Click! |
Gabpa | chr16_84875615_84875766 | 15645 | 0.141812 | 0.02 | 8.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_163602380_163602998 | 12.14 |
Ttpal |
tocopherol (alpha) transfer protein-like |
126 |
0.95 |
chr11_55032073_55032568 | 7.80 |
Anxa6 |
annexin A6 |
1095 |
0.47 |
chr5_86172879_86173210 | 7.19 |
Uba6 |
ubiquitin-like modifier activating enzyme 6 |
241 |
0.93 |
chr1_183388596_183388859 | 7.18 |
Taf1a |
TATA-box binding protein associated factor, RNA polymerase I, A |
254 |
0.88 |
chr3_139205048_139205621 | 7.10 |
Stpg2 |
sperm tail PG rich repeat containing 2 |
360 |
0.92 |
chr16_32003256_32003657 | 7.07 |
Senp5 |
SUMO/sentrin specific peptidase 5 |
169 |
0.89 |
chr2_132247782_132247933 | 7.01 |
Tmem230 |
transmembrane protein 230 |
50 |
0.96 |
chr11_70647317_70648216 | 6.97 |
Rnf167 |
ring finger protein 167 |
177 |
0.59 |
chr1_16688117_16689069 | 6.90 |
Ly96 |
lymphocyte antigen 96 |
85 |
0.96 |
chr13_91807673_91807950 | 6.76 |
Zcchc9 |
zinc finger, CCHC domain containing 9 |
106 |
0.96 |
chr17_6828020_6828603 | 6.71 |
4933426B08Rik |
RIKEN cDNA 4933426B08 gene |
19802 |
0.14 |
chr8_113635587_113636301 | 6.41 |
Mon1b |
MON1 homolog B, secretory traffciking associated |
109 |
0.96 |
chr11_48817088_48817421 | 6.40 |
Trim41 |
tripartite motif-containing 41 |
99 |
0.93 |
chr19_40873495_40873689 | 6.39 |
E030044B06Rik |
RIKEN cDNA E030044B06 gene |
5206 |
0.18 |
chr13_21362484_21362864 | 6.36 |
Zscan12 |
zinc finger and SCAN domain containing 12 |
146 |
0.9 |
chr8_70776836_70777199 | 6.32 |
2010320M18Rik |
RIKEN cDNA 2010320M18 gene |
202 |
0.57 |
chr7_79743122_79743441 | 6.32 |
Wdr93 |
WD repeat domain 93 |
118 |
0.53 |
chr16_32099836_32100211 | 6.32 |
Cep19 |
centrosomal protein 19 |
71 |
0.76 |
chr2_3799765_3800198 | 6.29 |
Fam107b |
family with sequence similarity 107, member B |
26035 |
0.16 |
chr3_95015790_95016220 | 6.22 |
4930481B07Rik |
RIKEN cDNA 4930481B07 gene |
244 |
0.68 |
chr19_6275855_6276520 | 6.20 |
Gm14963 |
predicted gene 14963 |
418 |
0.46 |
chr7_129591918_129592572 | 6.11 |
Wdr11 |
WD repeat domain 11 |
327 |
0.92 |
chr11_69580362_69581419 | 6.11 |
Trp53 |
transformation related protein 53 |
485 |
0.42 |
chr11_103142300_103143248 | 6.04 |
Hexim2 |
hexamethylene bis-acetamide inducible 2 |
8909 |
0.12 |
chr3_84582007_84582733 | 6.01 |
Arfip1 |
ADP-ribosylation factor interacting protein 1 |
115 |
0.96 |
chr18_31609208_31610197 | 5.95 |
B930094E09Rik |
RIKEN cDNA B930094E09 gene |
190 |
0.5 |
chr10_80226705_80227856 | 5.92 |
Pwwp3a |
PWWP domain containing 3A, DNA repair factor |
529 |
0.58 |
chr11_58866994_58868023 | 5.91 |
2810021J22Rik |
RIKEN cDNA 2810021J22 gene |
241 |
0.79 |
chr19_53943693_53944481 | 5.87 |
Bbip1 |
BBSome interacting protein 1 |
93 |
0.67 |
chr15_89373114_89374146 | 5.86 |
Sco2 |
SCO2 cytochrome c oxidase assembly protein |
188 |
0.84 |
chr1_118321880_118322905 | 5.79 |
Nifk |
nucleolar protein interacting with the FHA domain of MKI67 |
240 |
0.91 |
chr11_4895261_4896107 | 5.78 |
Thoc5 |
THO complex 5 |
341 |
0.82 |
chr10_83648738_83649029 | 5.68 |
Appl2 |
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 |
145 |
0.96 |
chr2_34826165_34826792 | 5.66 |
Fbxw2 |
F-box and WD-40 domain protein 2 |
167 |
0.91 |
chr8_125669445_125669835 | 5.64 |
Map10 |
microtubule-associated protein 10 |
178 |
0.96 |
chr2_5844951_5845177 | 5.60 |
Nudt5 |
nudix (nucleoside diphosphate linked moiety X)-type motif 5 |
30 |
0.57 |
chr19_6241712_6242757 | 5.54 |
Atg2a |
autophagy related 2A |
566 |
0.52 |
chr9_53829560_53830029 | 5.52 |
Slc35f2 |
solute carrier family 35, member F2 |
19077 |
0.16 |
chr12_83687826_83688219 | 5.47 |
Psen1 |
presenilin 1 |
130 |
0.94 |
chr16_84834297_84834988 | 5.44 |
Atp5j |
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F |
190 |
0.61 |
chr9_55208628_55208982 | 5.43 |
Fbxo22 |
F-box protein 22 |
120 |
0.96 |
chr3_33955842_33956444 | 5.42 |
4930502C17Rik |
RIKEN cDNA 4930502C17 gene |
57 |
0.96 |
chr2_167421218_167421702 | 5.41 |
Slc9a8 |
solute carrier family 9 (sodium/hydrogen exchanger), member 8 |
252 |
0.92 |
chr11_97050817_97052901 | 5.40 |
Gm11574 |
predicted gene 11574 |
427 |
0.42 |
chr17_35135244_35136480 | 5.34 |
Bag6 |
BCL2-associated athanogene 6 |
118 |
0.84 |
chr15_100550978_100551997 | 5.33 |
Tfcp2 |
transcription factor CP2 |
64 |
0.95 |
chr4_108999918_109000427 | 5.32 |
Nrd1 |
nardilysin, N-arginine dibasic convertase, NRD convertase 1 |
483 |
0.68 |
chr13_14039222_14040045 | 5.31 |
Tbce |
tubulin-specific chaperone E |
5 |
0.96 |
chr17_25823317_25824670 | 5.27 |
Wdr24 |
WD repeat domain 24 |
344 |
0.61 |
chr1_9744471_9745108 | 5.26 |
1700034P13Rik |
RIKEN cDNA 1700034P13 gene |
2859 |
0.19 |
chr18_15552243_15552975 | 5.25 |
Aqp4 |
aquaporin 4 |
141627 |
0.04 |
chr2_152687052_152688049 | 5.25 |
Mcts2 |
malignant T cell amplified sequence 2 |
515 |
0.64 |
chr4_130107260_130107551 | 5.22 |
Pef1 |
penta-EF hand domain containing 1 |
151 |
0.94 |
chr1_183296448_183297298 | 5.18 |
Brox |
BRO1 domain and CAAX motif containing |
119 |
0.58 |
chr2_153224755_153225797 | 5.12 |
Tspyl3 |
TSPY-like 3 |
165 |
0.93 |
chr9_121277015_121277690 | 5.12 |
Ulk4 |
unc-51-like kinase 4 |
155 |
0.77 |
chr17_72920336_72921423 | 5.07 |
Lbh |
limb-bud and heart |
309 |
0.93 |
chr17_25579224_25580012 | 5.07 |
Lmf1 |
lipase maturation factor 1 |
298 |
0.79 |
chr2_91649087_91649959 | 5.04 |
Zfp408 |
zinc finger protein 408 |
220 |
0.61 |
chr9_122886496_122886827 | 5.00 |
Zkscan7 |
zinc finger with KRAB and SCAN domains 7 |
976 |
0.36 |
chr18_5819935_5820571 | 5.00 |
Zeb1 |
zinc finger E-box binding homeobox 1 |
89172 |
0.08 |
chr8_84770692_84772567 | 4.98 |
Nfix |
nuclear factor I/X |
1767 |
0.22 |
chr9_37657249_37657542 | 4.95 |
Tbrg1 |
transforming growth factor beta regulated gene 1 |
83 |
0.94 |
chr14_55672309_55672677 | 4.94 |
Gmpr2 |
guanosine monophosphate reductase 2 |
110 |
0.73 |
chr5_98330252_98330760 | 4.94 |
Cfap299 |
cilia and flagella associated protein 299 |
1136 |
0.52 |
chr19_10895274_10895725 | 4.90 |
Prpf19 |
pre-mRNA processing factor 19 |
85 |
0.94 |
chr11_109650213_109650764 | 4.87 |
Prkar1a |
protein kinase, cAMP dependent regulatory, type I, alpha |
87 |
0.97 |
chr7_4518554_4518985 | 4.87 |
Tnni3 |
troponin I, cardiac 3 |
995 |
0.29 |
chr10_80433713_80433937 | 4.85 |
Tcf3 |
transcription factor 3 |
178 |
0.88 |
chr8_73353809_73354912 | 4.84 |
Large1 |
LARGE xylosyl- and glucuronyltransferase 1 |
820 |
0.75 |
chr12_8673668_8673985 | 4.84 |
Pum2 |
pumilio RNA-binding family member 2 |
308 |
0.92 |
chr7_100926314_100930096 | 4.83 |
Arhgef17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
3902 |
0.17 |
chr4_118620578_118620854 | 4.79 |
Cfap57 |
cilia and flagella associated protein 57 |
61 |
0.52 |
chr7_107665595_107666983 | 4.78 |
Ppfibp2 |
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
978 |
0.52 |
chr6_72347051_72347567 | 4.78 |
0610030E20Rik |
RIKEN cDNA 0610030E20 gene |
8 |
0.93 |
chr6_148212231_148212627 | 4.77 |
Ergic2 |
ERGIC and golgi 2 |
55 |
0.66 |
chr15_89088784_89089109 | 4.77 |
Selenoo |
selenoprotein O |
138 |
0.91 |
chr18_24121909_24122133 | 4.74 |
Ino80c |
INO80 complex subunit C |
68 |
0.98 |
chr8_121585668_121585898 | 4.74 |
Gm17786 |
predicted gene, 17786 |
4018 |
0.13 |
chr17_48001761_48002420 | 4.73 |
Gm14871 |
predicted gene 14871 |
1482 |
0.33 |
chr6_122810483_122810936 | 4.73 |
Gm5112 |
predicted gene 5112 |
461 |
0.67 |
chr1_43933382_43933844 | 4.72 |
Tpp2 |
tripeptidyl peptidase II |
34 |
0.97 |
chr10_95514417_95514995 | 4.72 |
Ube2n |
ubiquitin-conjugating enzyme E2N |
439 |
0.75 |
chr6_120835871_120836219 | 4.71 |
Bcl2l13 |
BCL2-like 13 (apoptosis facilitator) |
167 |
0.93 |
chr9_56866808_56868850 | 4.71 |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
2796 |
0.18 |
chr5_143757914_143758261 | 4.70 |
D130017N08Rik |
RIKEN cDNA D130017N08 gene |
267 |
0.9 |
chr11_90248978_90249192 | 4.69 |
Mmd |
monocyte to macrophage differentiation-associated |
371 |
0.89 |
chr7_24316792_24316979 | 4.68 |
Zfp94 |
zinc finger protein 94 |
219 |
0.8 |
chr10_96621648_96621921 | 4.67 |
Btg1 |
BTG anti-proliferation factor 1 |
4230 |
0.24 |
chr3_52510208_52510569 | 4.64 |
Gm30173 |
predicted gene, 30173 |
6576 |
0.26 |
chr11_51635219_51636145 | 4.62 |
Rmnd5b |
required for meiotic nuclear division 5 homolog B |
35 |
0.96 |
chr17_55959169_55959362 | 4.62 |
Yju2 |
YJU2 splicing factor |
41 |
0.58 |
chr9_57439089_57439658 | 4.59 |
Ppcdc |
phosphopantothenoylcysteine decarboxylase |
718 |
0.55 |
chr14_60251654_60252141 | 4.58 |
Gm49336 |
predicted gene, 49336 |
390 |
0.51 |
chr3_129724927_129725347 | 4.58 |
Egf |
epidermal growth factor |
50 |
0.96 |
chr4_48473425_48473716 | 4.55 |
Tex10 |
testis expressed gene 10 |
111 |
0.98 |
chr2_157367272_157367630 | 4.55 |
Manbal |
mannosidase, beta A, lysosomal-like |
143 |
0.95 |
chr15_81936444_81938042 | 4.53 |
Csdc2 |
cold shock domain containing C2, RNA binding |
261 |
0.82 |
chr18_61706798_61707705 | 4.52 |
Pcyox1l |
prenylcysteine oxidase 1 like |
362 |
0.78 |
chr13_23433175_23433449 | 4.52 |
C230035I16Rik |
RIKEN cDNA C230035I16 gene |
2290 |
0.14 |
chr2_167492818_167493398 | 4.49 |
Spata2 |
spermatogenesis associated 2 |
221 |
0.71 |
chr1_55130845_55131081 | 4.47 |
Mob4 |
MOB family member 4, phocein |
268 |
0.85 |
chr11_69670832_69671279 | 4.44 |
Eif4a1 |
eukaryotic translation initiation factor 4A1 |
167 |
0.77 |
chr19_3282559_3283552 | 4.42 |
Mrpl21 |
mitochondrial ribosomal protein L21 |
0 |
0.51 |
chr9_107628498_107629732 | 4.41 |
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting 2 |
2509 |
0.1 |
chr9_22003007_22003948 | 4.41 |
Prkcsh |
protein kinase C substrate 80K-H |
260 |
0.74 |
chr19_5106014_5106999 | 4.41 |
Rab1b |
RAB1B, member RAS oncogene family |
261 |
0.77 |
chr19_5771456_5771657 | 4.41 |
Scyl1 |
SCY1-like 1 (S. cerevisiae) |
137 |
0.89 |
chr6_147042566_147042769 | 4.41 |
Mrps35 |
mitochondrial ribosomal protein S35 |
97 |
0.95 |
chr18_61177095_61177644 | 4.39 |
Hmgxb3 |
HMG box domain containing 3 |
319 |
0.86 |
chr17_56256141_56256492 | 4.39 |
Fem1a |
fem 1 homolog a |
494 |
0.62 |
chr6_39573596_39573891 | 4.38 |
Adck2 |
aarF domain containing kinase 2 |
130 |
0.94 |
chr9_45906550_45906969 | 4.37 |
Rnf214 |
ring finger protein 214 |
102 |
0.61 |
chr1_94035083_94036007 | 4.37 |
Neu4 |
sialidase 4 |
15052 |
0.16 |
chr13_48231236_48231387 | 4.37 |
Gm36346 |
predicted gene, 36346 |
5940 |
0.17 |
chr17_74527551_74528023 | 4.35 |
Gm31645 |
predicted gene, 31645 |
143 |
0.83 |
chr5_31452372_31452865 | 4.32 |
Zfp512 |
zinc finger protein 512 |
100 |
0.72 |
chr15_27405650_27406408 | 4.31 |
Gm19111 |
predicted gene, 19111 |
38090 |
0.15 |
chr11_6199540_6200423 | 4.31 |
A730071L15Rik |
RIKEN cDNA A730071L15Rik gene |
48 |
0.86 |
chr7_24315921_24316627 | 4.29 |
Zfp94 |
zinc finger protein 94 |
308 |
0.72 |
chr11_69395478_69395684 | 4.27 |
Cyb5d1 |
cytochrome b5 domain containing 1 |
50 |
0.5 |
chr16_36040889_36041097 | 4.25 |
Wdr5b |
WD repeat domain 5B |
197 |
0.9 |
chr10_30200574_30200868 | 4.23 |
Cenpw |
centromere protein W |
161 |
0.96 |
chr16_62786873_62787244 | 4.23 |
Nsun3 |
NOL1/NOP2/Sun domain family member 3 |
240 |
0.91 |
chr7_101896365_101896653 | 4.23 |
Anapc15 |
anaphase promoting complex C subunit 15 |
81 |
0.93 |
chr1_190911532_190911812 | 4.22 |
Rps6kc1 |
ribosomal protein S6 kinase polypeptide 1 |
62 |
0.97 |
chr10_18234518_18235223 | 4.20 |
Ccdc28a |
coiled-coil domain containing 28A |
108 |
0.61 |
chr18_64516147_64516652 | 4.18 |
Nars |
asparaginyl-tRNA synthetase |
27 |
0.97 |
chr7_24111941_24112239 | 4.18 |
Zfp112 |
zinc finger protein 112 |
224 |
0.86 |
chr13_23368541_23369178 | 4.18 |
Zfp322a |
zinc finger protein 322A |
141 |
0.92 |
chr11_32533299_32533945 | 4.17 |
Stk10 |
serine/threonine kinase 10 |
317 |
0.86 |
chr3_89243498_89245184 | 4.15 |
Trim46 |
tripartite motif-containing 46 |
672 |
0.36 |
chr11_45678927_45679154 | 4.14 |
Gm22284 |
predicted gene, 22284 |
39657 |
0.17 |
chr11_3894522_3895167 | 4.14 |
4921536K21Rik |
RIKEN cDNA 4921536K21 gene |
254 |
0.61 |
chr8_60983455_60983912 | 4.14 |
B230317F23Rik |
RIKEN cDNA B230317F23 gene |
246 |
0.63 |
chr7_44857364_44857946 | 4.13 |
Pnkp |
polynucleotide kinase 3'- phosphatase |
261 |
0.76 |
chr16_11134834_11135167 | 4.13 |
Txndc11 |
thioredoxin domain containing 11 |
350 |
0.77 |
chr2_119112294_119112797 | 4.13 |
Rad51 |
RAD51 recombinase |
248 |
0.88 |
chr3_5576122_5576661 | 4.12 |
Pex2 |
peroxisomal biogenesis factor 2 |
152 |
0.97 |
chr4_41569775_41570085 | 4.12 |
Dnaic1 |
dynein, axonemal, intermediate chain 1 |
155 |
0.74 |
chr5_113137768_113139144 | 4.11 |
2900026A02Rik |
RIKEN cDNA 2900026A02 gene |
470 |
0.68 |
chr13_74591380_74592212 | 4.09 |
Gm46430 |
predicted gene, 46430 |
18238 |
0.12 |
chr6_112197716_112197937 | 4.09 |
1700054K19Rik |
RIKEN cDNA 1700054K19 gene |
12882 |
0.2 |
chr12_87266483_87267495 | 4.09 |
Gm47293 |
predicted gene, 47293 |
131 |
0.65 |
chr14_70780830_70781723 | 4.08 |
Dok2 |
docking protein 2 |
4566 |
0.21 |
chr6_85136892_85137313 | 4.07 |
Spr |
sepiapterin reductase |
654 |
0.47 |
chr3_123508630_123509202 | 4.07 |
Snhg8 |
small nucleolar RNA host gene 8 |
512 |
0.54 |
chr12_12263781_12264571 | 4.06 |
Fam49a |
family with sequence similarity 49, member A |
1987 |
0.46 |
chr11_55461186_55461620 | 4.06 |
Atox1 |
antioxidant 1 copper chaperone |
164 |
0.91 |
chr10_80590202_80590362 | 4.06 |
Abhd17a |
abhydrolase domain containing 17A |
33 |
0.86 |
chr1_72254318_72255021 | 4.06 |
Gm25939 |
predicted gene, 25939 |
339 |
0.81 |
chr7_143756400_143757574 | 4.05 |
Osbpl5 |
oxysterol binding protein-like 5 |
2 |
0.96 |
chr2_115581093_115581655 | 4.05 |
Gm13977 |
predicted gene 13977 |
181 |
0.69 |
chr19_33761196_33761926 | 4.05 |
Lipo3 |
lipase, member O3 |
390 |
0.81 |
chr7_44441951_44442938 | 4.04 |
Lrrc4b |
leucine rich repeat containing 4B |
41 |
0.93 |
chr5_93206542_93206720 | 4.02 |
2010109A12Rik |
RIKEN cDNA 2010109A12 gene |
98 |
0.55 |
chr17_26662860_26663786 | 4.02 |
Atp6v0e |
ATPase, H+ transporting, lysosomal V0 subunit E |
92 |
0.96 |
chr7_100121612_100121964 | 4.02 |
Pold3 |
polymerase (DNA-directed), delta 3, accessory subunit |
223 |
0.92 |
chr3_37642577_37643261 | 4.01 |
Gm43820 |
predicted gene 43820 |
1688 |
0.21 |
chr5_30913519_30915234 | 4.00 |
Emilin1 |
elastin microfibril interfacer 1 |
637 |
0.48 |
chr17_23546616_23547386 | 3.98 |
6330415G19Rik |
RIKEN cDNA 6330415G19 gene |
3798 |
0.1 |
chr10_81384008_81384456 | 3.98 |
Dohh |
deoxyhypusine hydroxylase/monooxygenase |
196 |
0.49 |
chr1_87755542_87755953 | 3.98 |
Atg16l1 |
autophagy related 16-like 1 (S. cerevisiae) |
123 |
0.95 |
chr17_32634501_32635224 | 3.97 |
Cyp4f37 |
cytochrome P450, family 4, subfamily f, polypeptide 37 |
160 |
0.92 |
chr11_61267250_61267457 | 3.95 |
Aldh3a2 |
aldehyde dehydrogenase family 3, subfamily A2 |
88 |
0.97 |
chr7_75455166_75455414 | 3.94 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
244 |
0.92 |
chr4_141060936_141061336 | 3.94 |
Crocc |
ciliary rootlet coiled-coil, rootletin |
586 |
0.61 |
chr18_24121634_24121887 | 3.94 |
Ino80c |
INO80 complex subunit C |
75 |
0.98 |
chr6_148896252_148896569 | 3.94 |
Caprin2 |
caprin family member 2 |
173 |
0.91 |
chr3_28780903_28781257 | 3.94 |
1700112D23Rik |
RIKEN cDNA 1700112D23 gene |
28 |
0.7 |
chr13_100107622_100108016 | 3.93 |
Serf1 |
small EDRK-rich factor 1 |
193 |
0.77 |
chr11_53707054_53707283 | 3.93 |
Rad50 |
RAD50 double strand break repair protein |
127 |
0.93 |
chr8_3516944_3517448 | 3.93 |
Pnpla6 |
patatin-like phospholipase domain containing 6 |
30 |
0.95 |
chr10_86705776_86706038 | 3.92 |
Ttc41 |
tetratricopeptide repeat domain 41 |
63 |
0.75 |
chr6_72362619_72362808 | 3.91 |
Rnf181 |
ring finger protein 181 |
281 |
0.81 |
chr12_113155063_113155966 | 3.90 |
Tedc1 |
tubulin epsilon and delta complex 1 |
907 |
0.4 |
chr11_102156393_102156640 | 3.88 |
Tmem101 |
transmembrane protein 101 |
112 |
0.92 |
chr6_77243534_77244121 | 3.88 |
Lrrtm1 |
leucine rich repeat transmembrane neuronal 1 |
905 |
0.69 |
chr2_27442422_27443138 | 3.88 |
Brd3os |
bromodomain containing 3, opposite strand |
277 |
0.87 |
chr17_56609244_56609682 | 3.87 |
Micos13 |
mitochondrial contact site and cristae organizing system subunit 13 |
217 |
0.87 |
chr5_115158397_115158757 | 3.87 |
Mlec |
malectin |
398 |
0.73 |
chr7_44867192_44867686 | 3.86 |
Ptov1 |
prostate tumor over expressed gene 1 |
15 |
0.93 |
chr13_112998291_112999283 | 3.86 |
Mcidas |
multiciliate differentiation and DNA synthesis associated cell cycle protein |
4942 |
0.11 |
chrX_103617032_103617338 | 3.85 |
Ftx |
Ftx transcript, Xist regulator (non-protein coding) |
231 |
0.85 |
chr8_4325268_4325664 | 3.84 |
Elavl1 |
ELAV (embryonic lethal, abnormal vision)-like 1 (Hu antigen R) |
53 |
0.72 |
chr2_150136839_150137071 | 3.84 |
Zfp120 |
zinc finger protein 120 |
247 |
0.91 |
chr16_44138294_44139384 | 3.84 |
Atp6v1a |
ATPase, H+ transporting, lysosomal V1 subunit A |
141 |
0.92 |
chr1_86504278_86504908 | 3.83 |
Ptma |
prothymosin alpha |
22133 |
0.12 |
chr7_24884065_24884446 | 3.83 |
Rps19 |
ribosomal protein S19 |
116 |
0.92 |
chr14_102979649_102980174 | 3.82 |
Kctd12 |
potassium channel tetramerisation domain containing 12 |
1640 |
0.28 |
chr2_84715491_84715694 | 3.82 |
Zdhhc5 |
zinc finger, DHHC domain containing 5 |
412 |
0.65 |
chr7_45922758_45923210 | 3.82 |
Ccdc114 |
coiled-coil domain containing 114 |
1088 |
0.21 |
chr11_70646040_70646191 | 3.82 |
Slc25a11 |
solute carrier family 25 (mitochondrial carrier oxoglutarate carrier), member 11 |
205 |
0.77 |
chr1_154204657_154205754 | 3.81 |
Zfp648 |
zinc finger protein 648 |
4018 |
0.23 |
chr10_127069286_127070246 | 3.80 |
Tspan31 |
tetraspanin 31 |
215 |
0.72 |
chr14_121878193_121878463 | 3.80 |
1810041H14Rik |
RIKEN cDNA 1810041H14 gene |
58 |
0.79 |
chr4_141147569_141147784 | 3.80 |
Fbxo42 |
F-box protein 42 |
237 |
0.88 |
chr5_136962077_136962306 | 3.80 |
Fis1 |
fission, mitochondrial 1 |
114 |
0.92 |
chr13_92530931_92531422 | 3.79 |
Zfyve16 |
zinc finger, FYVE domain containing 16 |
308 |
0.9 |
chr17_23790402_23790835 | 3.78 |
Srrm2 |
serine/arginine repetitive matrix 2 |
44 |
0.92 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 11.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
2.6 | 7.7 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
2.5 | 7.5 | GO:0019086 | late viral transcription(GO:0019086) |
2.5 | 15.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
2.4 | 9.8 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
2.4 | 7.3 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
2.3 | 16.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
2.3 | 6.9 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.3 | 11.4 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
2.2 | 6.7 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
2.2 | 2.2 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
2.2 | 6.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
2.2 | 6.5 | GO:0030242 | pexophagy(GO:0030242) |
2.1 | 6.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
2.0 | 6.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
2.0 | 6.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
2.0 | 6.0 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
2.0 | 5.9 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
1.9 | 7.8 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
1.9 | 5.7 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.9 | 9.4 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
1.9 | 7.5 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
1.9 | 5.6 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.9 | 1.9 | GO:0046349 | glucosamine metabolic process(GO:0006041) amino sugar biosynthetic process(GO:0046349) |
1.9 | 3.7 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
1.8 | 5.5 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
1.8 | 5.4 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.7 | 6.9 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.7 | 5.1 | GO:0046078 | dUMP metabolic process(GO:0046078) |
1.7 | 10.3 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
1.7 | 5.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.7 | 1.7 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
1.7 | 5.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.7 | 3.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.7 | 8.4 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
1.7 | 6.7 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
1.7 | 5.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
1.6 | 8.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
1.6 | 6.5 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
1.6 | 8.0 | GO:0021764 | amygdala development(GO:0021764) |
1.6 | 4.7 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.6 | 4.7 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
1.6 | 6.3 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
1.6 | 9.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
1.5 | 1.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
1.5 | 5.9 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
1.5 | 1.5 | GO:0032025 | response to cobalt ion(GO:0032025) |
1.5 | 4.4 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
1.4 | 1.4 | GO:0085020 | protein K27-linked ubiquitination(GO:0044314) protein K6-linked ubiquitination(GO:0085020) |
1.4 | 1.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.4 | 4.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.4 | 4.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
1.4 | 8.6 | GO:0007220 | Notch receptor processing(GO:0007220) |
1.4 | 4.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
1.4 | 4.2 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
1.4 | 12.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
1.4 | 4.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.4 | 4.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.4 | 6.9 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
1.4 | 4.1 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.4 | 4.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
1.4 | 4.1 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
1.4 | 4.1 | GO:0033121 | regulation of purine nucleotide catabolic process(GO:0033121) |
1.4 | 9.5 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
1.4 | 4.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
1.4 | 2.7 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.3 | 4.0 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
1.3 | 5.4 | GO:0051031 | tRNA transport(GO:0051031) |
1.3 | 4.0 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.3 | 4.0 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
1.3 | 6.7 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
1.3 | 5.3 | GO:0032202 | telomere assembly(GO:0032202) |
1.3 | 5.3 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
1.3 | 2.7 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
1.3 | 4.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.3 | 2.6 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
1.3 | 4.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
1.3 | 3.9 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.3 | 3.9 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
1.3 | 1.3 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
1.3 | 3.9 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
1.3 | 7.8 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
1.3 | 1.3 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
1.3 | 7.7 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.3 | 3.8 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
1.3 | 5.1 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
1.3 | 5.1 | GO:0035627 | ceramide transport(GO:0035627) |
1.3 | 5.0 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
1.2 | 10.0 | GO:0010388 | cullin deneddylation(GO:0010388) |
1.2 | 3.7 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
1.2 | 3.7 | GO:0051182 | coenzyme transport(GO:0051182) |
1.2 | 1.2 | GO:0021590 | cerebellum maturation(GO:0021590) |
1.2 | 3.7 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.2 | 4.9 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.2 | 4.9 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
1.2 | 7.4 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
1.2 | 4.9 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
1.2 | 6.1 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
1.2 | 4.9 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.2 | 4.9 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
1.2 | 1.2 | GO:0060631 | regulation of meiosis I(GO:0060631) |
1.2 | 2.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
1.2 | 4.8 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
1.2 | 3.6 | GO:0009838 | abscission(GO:0009838) |
1.2 | 6.0 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
1.2 | 9.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
1.2 | 3.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.2 | 7.1 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
1.2 | 1.2 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
1.2 | 7.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.2 | 3.5 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
1.2 | 3.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
1.2 | 11.6 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
1.2 | 3.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
1.2 | 3.5 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
1.1 | 3.4 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
1.1 | 2.3 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
1.1 | 6.9 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
1.1 | 2.3 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.1 | 14.9 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
1.1 | 10.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
1.1 | 8.0 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
1.1 | 1.1 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
1.1 | 8.0 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
1.1 | 6.8 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
1.1 | 3.4 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
1.1 | 3.4 | GO:0090148 | membrane fission(GO:0090148) |
1.1 | 2.3 | GO:0007619 | courtship behavior(GO:0007619) |
1.1 | 6.8 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
1.1 | 4.5 | GO:0060437 | lung growth(GO:0060437) |
1.1 | 2.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
1.1 | 1.1 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
1.1 | 8.9 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
1.1 | 3.3 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
1.1 | 1.1 | GO:0016556 | mRNA modification(GO:0016556) |
1.1 | 3.3 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
1.1 | 6.6 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
1.1 | 3.3 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
1.1 | 2.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
1.1 | 3.3 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
1.1 | 6.6 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
1.1 | 3.3 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
1.1 | 2.2 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.1 | 7.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.1 | 5.4 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.1 | 8.7 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
1.1 | 10.8 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
1.1 | 4.3 | GO:0048478 | replication fork protection(GO:0048478) |
1.1 | 2.1 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
1.1 | 3.2 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
1.1 | 4.3 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.1 | 3.2 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
1.1 | 5.3 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.1 | 5.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.1 | 4.2 | GO:0042891 | antibiotic transport(GO:0042891) |
1.0 | 2.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
1.0 | 9.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
1.0 | 3.1 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
1.0 | 3.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.0 | 5.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
1.0 | 3.1 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
1.0 | 2.1 | GO:0070384 | Harderian gland development(GO:0070384) |
1.0 | 3.1 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
1.0 | 2.1 | GO:1903416 | response to glycoside(GO:1903416) |
1.0 | 1.0 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
1.0 | 5.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.0 | 3.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
1.0 | 4.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.0 | 1.0 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.0 | 4.1 | GO:0030035 | microspike assembly(GO:0030035) |
1.0 | 5.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
1.0 | 7.1 | GO:0097264 | self proteolysis(GO:0097264) |
1.0 | 10.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
1.0 | 6.1 | GO:0000012 | single strand break repair(GO:0000012) |
1.0 | 3.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
1.0 | 2.0 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
1.0 | 3.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.0 | 5.0 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
1.0 | 5.0 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
1.0 | 6.0 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
1.0 | 3.0 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.0 | 2.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
1.0 | 3.0 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.0 | 3.0 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
1.0 | 3.9 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
1.0 | 5.9 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
1.0 | 2.9 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
1.0 | 2.9 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.0 | 1.9 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
1.0 | 5.8 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
1.0 | 3.9 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
1.0 | 2.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.0 | 2.9 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
1.0 | 1.0 | GO:0060174 | limb bud formation(GO:0060174) |
1.0 | 1.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.9 | 14.2 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.9 | 3.8 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.9 | 4.7 | GO:0022605 | oogenesis stage(GO:0022605) |
0.9 | 3.8 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.9 | 0.9 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.9 | 3.8 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.9 | 10.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.9 | 4.7 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.9 | 3.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.9 | 3.8 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.9 | 5.6 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.9 | 3.7 | GO:0042255 | ribosome assembly(GO:0042255) |
0.9 | 1.9 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.9 | 0.9 | GO:0051231 | spindle elongation(GO:0051231) |
0.9 | 0.9 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.9 | 2.8 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.9 | 0.9 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.9 | 5.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.9 | 0.9 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.9 | 0.9 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.9 | 3.7 | GO:0035106 | operant conditioning(GO:0035106) |
0.9 | 6.4 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.9 | 0.9 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.9 | 2.8 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.9 | 3.7 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.9 | 3.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.9 | 0.9 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.9 | 1.8 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.9 | 1.8 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.9 | 1.8 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.9 | 2.7 | GO:0015755 | fructose transport(GO:0015755) |
0.9 | 1.8 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.9 | 10.0 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.9 | 2.7 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.9 | 2.7 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.9 | 3.6 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.9 | 2.7 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.9 | 10.0 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.9 | 12.7 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.9 | 2.7 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.9 | 2.7 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.9 | 0.9 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.9 | 3.6 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.9 | 1.8 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.9 | 3.6 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.9 | 1.8 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.9 | 3.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.9 | 1.8 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.9 | 1.8 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.9 | 0.9 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.9 | 2.6 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.9 | 1.7 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.9 | 1.7 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) chromosome movement towards spindle pole(GO:0051305) |
0.9 | 1.7 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.9 | 2.6 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.9 | 2.6 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.9 | 3.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.9 | 1.7 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.9 | 3.5 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.9 | 9.5 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.9 | 1.7 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.9 | 13.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.9 | 2.6 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.9 | 2.6 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.8 | 1.7 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.8 | 3.4 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.8 | 2.5 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.8 | 0.8 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.8 | 0.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.8 | 3.3 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.8 | 3.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.8 | 3.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.8 | 9.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.8 | 2.5 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.8 | 3.3 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.8 | 2.5 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.8 | 5.8 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.8 | 2.5 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.8 | 4.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.8 | 2.5 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.8 | 0.8 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.8 | 2.5 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.8 | 5.7 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.8 | 0.8 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.8 | 2.4 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.8 | 2.4 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.8 | 5.7 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.8 | 7.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.8 | 2.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.8 | 6.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.8 | 0.8 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.8 | 5.6 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.8 | 0.8 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.8 | 2.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.8 | 2.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.8 | 2.4 | GO:0021586 | pons maturation(GO:0021586) |
0.8 | 3.2 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.8 | 3.2 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.8 | 3.2 | GO:0072126 | positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
0.8 | 4.7 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.8 | 2.4 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.8 | 0.8 | GO:0030576 | Cajal body organization(GO:0030576) |
0.8 | 0.8 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.8 | 8.6 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.8 | 1.6 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.8 | 2.3 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.8 | 3.9 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.8 | 3.1 | GO:0008228 | opsonization(GO:0008228) |
0.8 | 4.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.8 | 2.3 | GO:0007525 | somatic muscle development(GO:0007525) |
0.8 | 2.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.8 | 4.7 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.8 | 2.3 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.8 | 0.8 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.8 | 5.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.8 | 2.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.8 | 1.5 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.8 | 0.8 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.8 | 2.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.8 | 3.8 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.8 | 3.8 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.8 | 15.3 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.8 | 6.9 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.8 | 1.5 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.8 | 1.5 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.8 | 3.0 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.8 | 4.5 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.8 | 1.5 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.8 | 6.8 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.8 | 2.3 | GO:0015888 | thiamine transport(GO:0015888) |
0.8 | 2.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.8 | 2.3 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.8 | 3.0 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
0.8 | 0.8 | GO:0015884 | folic acid transport(GO:0015884) |
0.8 | 3.0 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.8 | 0.8 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.8 | 4.5 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.8 | 2.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.7 | 0.7 | GO:0072197 | ureter morphogenesis(GO:0072197) |
0.7 | 9.7 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.7 | 2.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.7 | 0.7 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.7 | 4.5 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.7 | 2.2 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.7 | 26.0 | GO:0006400 | tRNA modification(GO:0006400) |
0.7 | 10.4 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.7 | 3.7 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.7 | 8.9 | GO:0060074 | synapse maturation(GO:0060074) |
0.7 | 5.2 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.7 | 2.9 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.7 | 4.4 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.7 | 0.7 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.7 | 6.5 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.7 | 12.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.7 | 2.2 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.7 | 9.4 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.7 | 1.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.7 | 1.4 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.7 | 2.2 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.7 | 1.4 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.7 | 1.4 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.7 | 0.7 | GO:1903232 | melanosome assembly(GO:1903232) |
0.7 | 2.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.7 | 12.2 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.7 | 2.2 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.7 | 1.4 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.7 | 1.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.7 | 2.1 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.7 | 2.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.7 | 3.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.7 | 2.1 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.7 | 5.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.7 | 2.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.7 | 5.0 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.7 | 0.7 | GO:1901629 | regulation of presynaptic membrane organization(GO:1901629) |
0.7 | 1.4 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.7 | 2.8 | GO:0043144 | snoRNA processing(GO:0043144) |
0.7 | 4.9 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.7 | 0.7 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.7 | 2.8 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.7 | 2.8 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.7 | 1.4 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.7 | 1.4 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.7 | 4.2 | GO:0031167 | rRNA methylation(GO:0031167) |
0.7 | 6.2 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.7 | 3.5 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.7 | 2.1 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.7 | 2.8 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.7 | 0.7 | GO:1990173 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.7 | 0.7 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.7 | 5.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.7 | 3.4 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.7 | 2.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.7 | 0.7 | GO:0071569 | protein ufmylation(GO:0071569) |
0.7 | 2.7 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.7 | 2.7 | GO:0009650 | UV protection(GO:0009650) |
0.7 | 2.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.7 | 2.7 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.7 | 0.7 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.7 | 3.4 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.7 | 4.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.7 | 2.0 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.7 | 2.7 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.7 | 2.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.7 | 3.4 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.7 | 2.0 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.7 | 0.7 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.7 | 4.1 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.7 | 1.4 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.7 | 13.6 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.7 | 0.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.7 | 2.7 | GO:0019695 | choline metabolic process(GO:0019695) |
0.7 | 2.7 | GO:0015808 | L-alanine transport(GO:0015808) |
0.7 | 1.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.7 | 27.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.7 | 1.3 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.7 | 2.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.7 | 5.4 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.7 | 12.7 | GO:1901998 | toxin transport(GO:1901998) |
0.7 | 1.3 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.7 | 13.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.7 | 0.7 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.7 | 2.0 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.7 | 2.0 | GO:0003032 | detection of oxygen(GO:0003032) |
0.7 | 3.3 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.7 | 2.6 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.7 | 1.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.7 | 0.7 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.7 | 3.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.7 | 2.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.7 | 2.6 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.7 | 0.7 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.7 | 3.9 | GO:0006108 | malate metabolic process(GO:0006108) |
0.7 | 5.2 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.7 | 0.7 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.7 | 2.6 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.6 | 3.9 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.6 | 3.9 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.6 | 2.6 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.6 | 2.6 | GO:0030091 | protein repair(GO:0030091) |
0.6 | 4.5 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.6 | 5.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.6 | 1.3 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.6 | 5.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.6 | 2.6 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.6 | 1.9 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.6 | 1.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.6 | 2.6 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.6 | 3.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.6 | 1.3 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.6 | 1.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.6 | 1.9 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.6 | 1.9 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.6 | 0.6 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.6 | 3.8 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.6 | 1.9 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.6 | 8.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.6 | 1.3 | GO:0006868 | glutamine transport(GO:0006868) |
0.6 | 0.6 | GO:0060399 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.6 | 0.6 | GO:0002159 | desmosome assembly(GO:0002159) |
0.6 | 0.6 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.6 | 8.2 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.6 | 3.7 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.6 | 2.5 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.6 | 0.6 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.6 | 1.2 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.6 | 6.8 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.6 | 1.9 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.6 | 1.2 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.6 | 0.6 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.6 | 4.9 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.6 | 0.6 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.6 | 3.7 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.6 | 1.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.6 | 2.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.6 | 1.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.6 | 1.2 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.6 | 1.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.6 | 7.3 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.6 | 1.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.6 | 16.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.6 | 1.2 | GO:0021824 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
0.6 | 3.0 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.6 | 3.7 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.6 | 3.0 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.6 | 1.8 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.6 | 1.8 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.6 | 4.2 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.6 | 6.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.6 | 2.4 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.6 | 1.8 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.6 | 2.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.6 | 0.6 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.6 | 1.8 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.6 | 1.2 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.6 | 1.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.6 | 1.8 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.6 | 1.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.6 | 5.4 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.6 | 14.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.6 | 1.8 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.6 | 1.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.6 | 11.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.6 | 5.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.6 | 4.2 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.6 | 4.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.6 | 1.2 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.6 | 3.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.6 | 0.6 | GO:1902592 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.6 | 7.7 | GO:0045116 | protein neddylation(GO:0045116) |
0.6 | 0.6 | GO:1901673 | regulation of spindle assembly(GO:0090169) regulation of mitotic spindle assembly(GO:1901673) |
0.6 | 2.4 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.6 | 0.6 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.6 | 5.3 | GO:0007097 | nuclear migration(GO:0007097) |
0.6 | 4.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.6 | 1.2 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.6 | 1.8 | GO:0060166 | olfactory pit development(GO:0060166) |
0.6 | 2.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.6 | 6.4 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.6 | 1.8 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.6 | 1.7 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.6 | 2.9 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.6 | 1.7 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.6 | 19.2 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.6 | 5.8 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.6 | 2.3 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.6 | 1.2 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.6 | 1.2 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.6 | 1.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.6 | 1.2 | GO:0086011 | membrane repolarization during action potential(GO:0086011) |
0.6 | 2.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.6 | 1.2 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.6 | 2.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.6 | 2.9 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.6 | 5.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.6 | 1.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.6 | 1.1 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.6 | 5.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.6 | 8.6 | GO:0044804 | nucleophagy(GO:0044804) |
0.6 | 7.4 | GO:0006465 | signal peptide processing(GO:0006465) |
0.6 | 2.3 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.6 | 1.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.6 | 1.7 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.6 | 1.7 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.6 | 16.9 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.6 | 3.4 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.6 | 6.2 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.6 | 1.7 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.6 | 2.2 | GO:0044849 | estrous cycle(GO:0044849) |
0.6 | 2.8 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.6 | 3.9 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.6 | 1.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.6 | 12.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.6 | 3.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.6 | 1.1 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.6 | 7.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.6 | 1.7 | GO:0045869 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.6 | 0.6 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.6 | 0.6 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.6 | 2.8 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.6 | 2.2 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.6 | 1.7 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.6 | 2.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.6 | 1.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.6 | 5.0 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.6 | 7.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.6 | 4.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.6 | 1.7 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.6 | 1.7 | GO:0019042 | viral latency(GO:0019042) |
0.5 | 1.1 | GO:0048678 | response to axon injury(GO:0048678) |
0.5 | 1.6 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.5 | 2.7 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.5 | 1.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.5 | 1.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.5 | 0.5 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.5 | 7.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.5 | 4.9 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.5 | 0.5 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.5 | 2.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.5 | 2.2 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.5 | 9.8 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.5 | 1.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.5 | 2.7 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.5 | 1.6 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.5 | 2.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.5 | 12.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.5 | 1.1 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.5 | 2.1 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.5 | 1.6 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.5 | 0.5 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.5 | 1.1 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.5 | 1.6 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.5 | 9.6 | GO:0098930 | axonal transport(GO:0098930) |
0.5 | 1.1 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.5 | 0.5 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.5 | 1.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.5 | 0.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.5 | 1.1 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.5 | 6.3 | GO:0031114 | regulation of microtubule depolymerization(GO:0031114) |
0.5 | 0.5 | GO:0097490 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.5 | 2.6 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.5 | 2.1 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.5 | 17.9 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.5 | 1.6 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.5 | 3.7 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.5 | 4.2 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.5 | 1.6 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.5 | 19.4 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.5 | 1.0 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.5 | 3.7 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.5 | 1.0 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.5 | 4.7 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.5 | 2.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.5 | 1.0 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.5 | 16.7 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.5 | 0.5 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.5 | 5.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.5 | 6.2 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.5 | 6.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.5 | 0.5 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.5 | 1.6 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.5 | 1.6 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.5 | 0.5 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.5 | 1.0 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.5 | 2.1 | GO:0015819 | lysine transport(GO:0015819) |
0.5 | 1.0 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
0.5 | 1.0 | GO:0014062 | regulation of serotonin secretion(GO:0014062) |
0.5 | 0.5 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.5 | 0.5 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.5 | 1.5 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.5 | 1.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.5 | 1.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.5 | 0.5 | GO:0070198 | protein localization to chromosome, telomeric region(GO:0070198) |
0.5 | 4.6 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.5 | 2.0 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.5 | 2.0 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.5 | 3.6 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.5 | 3.0 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.5 | 0.5 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.5 | 1.0 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.5 | 2.0 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.5 | 2.0 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.5 | 2.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.5 | 4.0 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.5 | 1.5 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.5 | 14.6 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.5 | 1.5 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.5 | 1.5 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.5 | 2.0 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.5 | 1.0 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.5 | 1.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.5 | 1.0 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.5 | 1.0 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.5 | 4.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.5 | 9.9 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.5 | 1.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.5 | 3.9 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.5 | 0.5 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.5 | 0.5 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.5 | 3.4 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.5 | 1.0 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.5 | 2.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.5 | 5.9 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.5 | 3.9 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.5 | 2.5 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.5 | 5.4 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.5 | 1.5 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.5 | 2.0 | GO:0031113 | regulation of microtubule polymerization(GO:0031113) |
0.5 | 1.9 | GO:0046851 | negative regulation of bone remodeling(GO:0046851) |
0.5 | 1.0 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.5 | 1.9 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.5 | 8.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.5 | 5.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.5 | 1.0 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.5 | 1.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.5 | 2.4 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.5 | 0.5 | GO:0048102 | autophagic cell death(GO:0048102) |
0.5 | 1.0 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.5 | 1.0 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.5 | 0.5 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.5 | 2.9 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.5 | 2.9 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.5 | 1.9 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.5 | 0.5 | GO:0071436 | sodium ion export(GO:0071436) |
0.5 | 2.4 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.5 | 1.9 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.5 | 4.3 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.5 | 7.6 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.5 | 0.5 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.5 | 0.5 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.5 | 2.8 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.5 | 1.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.5 | 1.4 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.5 | 0.9 | GO:0006266 | DNA ligation(GO:0006266) |
0.5 | 0.9 | GO:0044321 | response to leptin(GO:0044321) |
0.5 | 1.9 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.5 | 1.4 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.5 | 1.4 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.5 | 1.4 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.5 | 0.9 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.5 | 2.8 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.5 | 0.9 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.5 | 4.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.5 | 1.4 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.5 | 1.8 | GO:0042637 | catagen(GO:0042637) |
0.5 | 1.8 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.5 | 1.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.5 | 1.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.5 | 2.3 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.5 | 4.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.5 | 1.8 | GO:0046110 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.5 | 0.9 | GO:0033058 | directional locomotion(GO:0033058) |
0.5 | 0.9 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.5 | 3.6 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.5 | 2.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.5 | 3.2 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.4 | 0.4 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.4 | 1.3 | GO:0060179 | male mating behavior(GO:0060179) |
0.4 | 4.0 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.4 | 0.9 | GO:0032231 | regulation of actin filament bundle assembly(GO:0032231) |
0.4 | 0.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.4 | 9.3 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.4 | 0.4 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.4 | 0.4 | GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway(GO:0090081) |
0.4 | 1.8 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.4 | 2.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.4 | 0.9 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.4 | 3.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.4 | 1.3 | GO:0010225 | response to UV-C(GO:0010225) |
0.4 | 1.3 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.4 | 0.4 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.4 | 0.9 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.4 | 1.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.4 | 3.1 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.4 | 13.9 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.4 | 0.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.4 | 0.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.4 | 1.3 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.4 | 0.4 | GO:2000049 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.4 | 0.4 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
0.4 | 0.9 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.4 | 0.4 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.4 | 2.6 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.4 | 2.2 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.4 | 1.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.4 | 0.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.4 | 0.9 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
0.4 | 0.9 | GO:0090399 | replicative senescence(GO:0090399) |
0.4 | 4.7 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.4 | 0.9 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.4 | 0.4 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.4 | 0.4 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.4 | 1.3 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.4 | 0.8 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.4 | 3.4 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.4 | 1.3 | GO:0015074 | DNA integration(GO:0015074) |
0.4 | 0.4 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.4 | 1.3 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.4 | 1.3 | GO:0000032 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.4 | 0.4 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.4 | 8.5 | GO:0001964 | startle response(GO:0001964) |
0.4 | 0.4 | GO:1902896 | terminal web assembly(GO:1902896) |
0.4 | 3.8 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.4 | 0.8 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.4 | 5.9 | GO:0006301 | postreplication repair(GO:0006301) |
0.4 | 3.4 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.4 | 5.9 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.4 | 2.5 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.4 | 1.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.4 | 0.4 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.4 | 2.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.4 | 0.4 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.4 | 0.4 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
0.4 | 0.8 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.4 | 10.4 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.4 | 2.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.4 | 0.8 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.4 | 1.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.4 | 3.7 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.4 | 1.2 | GO:0075733 | intracellular transport of virus(GO:0075733) multi-organism intracellular transport(GO:1902583) |
0.4 | 0.8 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.4 | 2.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.4 | 5.8 | GO:0009060 | aerobic respiration(GO:0009060) |
0.4 | 1.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.4 | 0.4 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.4 | 6.2 | GO:0007094 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.4 | 1.6 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.4 | 0.8 | GO:0042348 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.4 | 0.4 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.4 | 2.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.4 | 1.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.4 | 0.4 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.4 | 0.4 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.4 | 2.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 1.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.4 | 0.8 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.4 | 1.6 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.4 | 1.6 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.4 | 4.8 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.4 | 1.2 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.4 | 1.6 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.4 | 0.8 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.4 | 0.8 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.4 | 2.0 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.4 | 1.2 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.4 | 1.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.4 | 0.8 | GO:0001302 | replicative cell aging(GO:0001302) |
0.4 | 0.8 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.4 | 3.2 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.4 | 1.2 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.4 | 3.2 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.4 | 1.2 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.4 | 1.2 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.4 | 2.4 | GO:0007031 | peroxisome organization(GO:0007031) |
0.4 | 1.6 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.4 | 0.8 | GO:0048254 | snoRNA localization(GO:0048254) |
0.4 | 0.8 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.4 | 5.5 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.4 | 0.8 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.4 | 1.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.4 | 0.4 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.4 | 2.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.4 | 1.6 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.4 | 6.6 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.4 | 2.7 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.4 | 3.1 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.4 | 1.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.4 | 3.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.4 | 1.2 | GO:0032328 | alanine transport(GO:0032328) |
0.4 | 5.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.4 | 1.9 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.4 | 0.4 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.4 | 3.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.4 | 1.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.4 | 0.4 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.4 | 3.1 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.4 | 0.4 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.4 | 1.9 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.4 | 8.8 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.4 | 1.9 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.4 | 0.4 | GO:0014819 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) regulation of skeletal muscle contraction(GO:0014819) |
0.4 | 0.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.4 | 1.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.4 | 2.3 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.4 | 2.3 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.4 | 1.1 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.4 | 3.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.4 | 1.5 | GO:0048069 | eye pigmentation(GO:0048069) |
0.4 | 0.8 | GO:0021756 | striatum development(GO:0021756) |
0.4 | 3.4 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.4 | 1.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.4 | 1.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.4 | 0.4 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.4 | 0.4 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.4 | 0.8 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.4 | 1.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.4 | 1.5 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.4 | 1.1 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.4 | 3.4 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.4 | 1.9 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.4 | 0.4 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.4 | 24.0 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.4 | 0.4 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.4 | 1.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.4 | 1.1 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.4 | 0.4 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.4 | 0.7 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.4 | 2.9 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.4 | 0.7 | GO:0070266 | necroptotic process(GO:0070266) |
0.4 | 4.4 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.4 | 2.9 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.4 | 1.8 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.4 | 3.6 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.4 | 0.4 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.4 | 4.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.4 | 10.9 | GO:0008033 | tRNA metabolic process(GO:0006399) tRNA processing(GO:0008033) |
0.4 | 1.1 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.4 | 1.8 | GO:0030261 | chromosome condensation(GO:0030261) |
0.4 | 1.8 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.4 | 1.8 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.4 | 2.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.4 | 1.1 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.4 | 3.2 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.4 | 1.1 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.4 | 1.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.4 | 0.4 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.4 | 7.5 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.4 | 1.1 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.4 | 1.4 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.4 | 6.7 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.4 | 11.6 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
0.4 | 0.7 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.3 | 3.8 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.3 | 1.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 1.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.3 | 0.7 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.3 | 1.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 0.3 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.3 | 1.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.3 | 5.5 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.3 | 1.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.3 | 0.3 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) |
0.3 | 0.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.3 | 0.7 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.3 | 1.7 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.3 | 0.3 | GO:0072553 | terminal button organization(GO:0072553) |
0.3 | 0.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 | 0.3 | GO:0097531 | mast cell migration(GO:0097531) |
0.3 | 1.0 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.3 | 1.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.3 | 2.0 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.3 | 0.7 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.3 | 1.4 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.3 | 27.4 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.3 | 0.3 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.3 | 2.7 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
0.3 | 2.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.3 | 1.7 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.3 | 2.4 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.3 | 1.7 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.3 | 0.7 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 2.3 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.3 | 1.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 6.0 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.3 | 0.3 | GO:1902579 | multi-organism transport(GO:0044766) multi-organism localization(GO:1902579) |
0.3 | 1.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.3 | 1.0 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.3 | 0.3 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.3 | 2.0 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.3 | 6.2 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.3 | 3.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.3 | 1.0 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.3 | 1.6 | GO:1900117 | regulation of execution phase of apoptosis(GO:1900117) |
0.3 | 1.0 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.3 | 0.6 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.3 | 0.3 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.3 | 0.3 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.3 | 1.9 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.3 | 1.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.3 | 1.9 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.3 | 3.9 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.3 | 1.9 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.3 | 0.3 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.3 | 1.3 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) |
0.3 | 0.6 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 1.0 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.3 | 1.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.3 | 0.3 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.3 | 13.0 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.3 | 1.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.3 | 0.9 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.3 | 5.0 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.3 | 0.6 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.3 | 0.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.3 | 3.8 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.3 | 1.6 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.3 | 0.9 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.3 | 0.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.3 | 0.6 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.3 | 0.3 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.3 | 0.3 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.3 | 3.7 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.3 | 16.0 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.3 | 1.2 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.3 | 0.9 | GO:0014028 | notochord formation(GO:0014028) |
0.3 | 0.6 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.3 | 0.6 | GO:0032456 | endocytic recycling(GO:0032456) |
0.3 | 0.9 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.3 | 0.6 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.3 | 1.2 | GO:0035989 | tendon development(GO:0035989) |
0.3 | 2.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.3 | 0.9 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.3 | 0.3 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.3 | 1.8 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.3 | 0.3 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.3 | 0.3 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.3 | 0.9 | GO:0010165 | response to X-ray(GO:0010165) |
0.3 | 2.1 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.3 | 0.6 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.3 | 2.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.3 | 0.3 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.3 | 0.6 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.3 | 0.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 0.9 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.3 | 0.6 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 0.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.3 | 0.9 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.3 | 1.2 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.3 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 9.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.3 | 0.3 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.3 | 0.6 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.3 | 0.3 | GO:0048753 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.3 | 0.3 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.3 | 0.3 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.3 | 1.2 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.3 | 5.2 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.3 | 1.4 | GO:0031000 | response to caffeine(GO:0031000) |
0.3 | 0.3 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.3 | 0.3 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.3 | 0.6 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.3 | 0.6 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.3 | 0.3 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.3 | 1.1 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.3 | 1.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 3.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.3 | 0.3 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.3 | 1.4 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.3 | 0.8 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.3 | 0.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.3 | 7.3 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.3 | 0.8 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.3 | 0.8 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.3 | 0.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.3 | 0.3 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.3 | 0.6 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.3 | 0.6 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.3 | 1.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.3 | 0.6 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.3 | 1.4 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
0.3 | 1.1 | GO:0042438 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.3 | 0.6 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.3 | 1.1 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.3 | 0.6 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.3 | 9.1 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.3 | 5.5 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.3 | 0.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 0.8 | GO:0015867 | ATP transport(GO:0015867) |
0.3 | 0.3 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.3 | 3.3 | GO:0006414 | translational elongation(GO:0006414) |
0.3 | 0.5 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.3 | 0.3 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.3 | 0.3 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.3 | 0.8 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.3 | 5.6 | GO:0035082 | axoneme assembly(GO:0035082) |
0.3 | 1.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.3 | 1.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.3 | 1.1 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.3 | 0.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.3 | 0.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.3 | 1.9 | GO:0036065 | fucosylation(GO:0036065) |
0.3 | 0.8 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 1.1 | GO:0032570 | response to progesterone(GO:0032570) |
0.3 | 1.6 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.3 | 1.3 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.3 | 1.3 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.3 | 0.5 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.3 | 0.3 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.3 | 0.3 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.3 | 0.5 | GO:0003097 | renal water transport(GO:0003097) glycerol transport(GO:0015793) renal water absorption(GO:0070295) |
0.3 | 0.5 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.3 | 3.1 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 4.9 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.3 | 0.8 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.3 | 2.1 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.3 | 0.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.3 | 0.8 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.3 | 0.3 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.3 | 1.3 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.3 | 1.0 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.3 | 0.8 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.3 | 1.5 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.3 | 0.3 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.3 | 1.5 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.3 | 1.3 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.3 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 5.3 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.3 | 0.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.3 | 0.3 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.3 | 3.0 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.3 | 3.0 | GO:0007032 | endosome organization(GO:0007032) |
0.3 | 1.5 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.3 | 0.3 | GO:0097503 | sialylation(GO:0097503) |
0.3 | 2.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.3 | 1.0 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.3 | 0.3 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.3 | 2.0 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 2.0 | GO:1901571 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
0.2 | 1.2 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.2 | 1.2 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 1.0 | GO:0009303 | rRNA transcription(GO:0009303) |
0.2 | 1.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 0.5 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.2 | 1.0 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.2 | 1.7 | GO:0015992 | proton transport(GO:0015992) |
0.2 | 0.5 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.2 | 0.5 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 2.9 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.2 | 0.5 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.2 | 0.5 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.2 | 1.0 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.7 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.2 | 0.5 | GO:0051665 | membrane raft localization(GO:0051665) |
0.2 | 0.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.2 | 0.2 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 0.7 | GO:0006903 | vesicle targeting(GO:0006903) |
0.2 | 1.4 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 2.2 | GO:0043113 | receptor clustering(GO:0043113) |
0.2 | 0.2 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.2 | 0.7 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.2 | 5.3 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 1.4 | GO:0007614 | short-term memory(GO:0007614) |
0.2 | 2.6 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 1.0 | GO:0032506 | cytokinetic process(GO:0032506) |
0.2 | 0.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 3.8 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.2 | 0.7 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 0.7 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.2 | 0.5 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.2 | 0.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.2 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.2 | 0.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.2 | 0.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 0.9 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.2 | 1.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.2 | 0.9 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.2 | 0.7 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 0.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 0.7 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.2 | 0.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.2 | 0.9 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.2 | 1.4 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.2 | 0.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 0.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 5.3 | GO:0022900 | electron transport chain(GO:0022900) |
0.2 | 1.1 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.2 | 1.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.2 | 0.2 | GO:0046131 | pyrimidine ribonucleoside metabolic process(GO:0046131) |
0.2 | 0.2 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.2 | 0.2 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.2 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 1.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.5 | GO:0030239 | myofibril assembly(GO:0030239) |
0.2 | 0.7 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 2.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 1.1 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.2 | 0.4 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.2 | 3.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.2 | 0.9 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 0.9 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 0.4 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 0.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 0.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.2 | 1.8 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.2 | 2.0 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.2 | 3.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.2 | 2.0 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 0.2 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.2 | 0.2 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.2 | 0.4 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.2 | 0.4 | GO:0002432 | granuloma formation(GO:0002432) |
0.2 | 1.7 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 0.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 1.3 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.2 | 1.9 | GO:0006165 | nucleoside diphosphate phosphorylation(GO:0006165) |
0.2 | 0.8 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 0.8 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 0.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 2.3 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.2 | 0.4 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.4 | GO:0042711 | maternal behavior(GO:0042711) |
0.2 | 0.8 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 1.0 | GO:0016241 | regulation of macroautophagy(GO:0016241) |
0.2 | 0.6 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 1.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 15.1 | GO:0044782 | cilium organization(GO:0044782) |
0.2 | 0.4 | GO:0035425 | autocrine signaling(GO:0035425) |
0.2 | 0.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 0.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.2 | 0.6 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.2 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 0.2 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 1.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 0.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 1.2 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.2 | 0.6 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.2 | 1.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 2.0 | GO:0098534 | centriole assembly(GO:0098534) |
0.2 | 0.2 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.2 | 0.6 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.2 | 1.2 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.2 | 3.2 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.2 | 0.6 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 1.2 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 0.6 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.2 | 2.6 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.2 | 0.2 | GO:0018158 | protein oxidation(GO:0018158) |
0.2 | 1.4 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 0.4 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.2 | 0.6 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.2 | 1.4 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.2 | 0.6 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.2 | 0.6 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.2 | 0.4 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.2 | 1.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.2 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.6 | GO:0099622 | cardiac muscle cell membrane repolarization(GO:0099622) |
0.2 | 0.8 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.2 | 0.2 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.2 | 5.5 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.2 | 2.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 0.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 0.4 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.2 | 9.6 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.2 | 0.2 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.2 | 4.4 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.2 | 4.2 | GO:0071897 | DNA biosynthetic process(GO:0071897) |
0.2 | 0.4 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.2 | 1.3 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.2 | 9.3 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
0.2 | 0.4 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.2 | 1.9 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 0.4 | GO:0044359 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) |
0.2 | 0.8 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.2 | 3.0 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 1.3 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.2 | 0.4 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 1.3 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.2 | 0.6 | GO:0061025 | membrane fusion(GO:0061025) |
0.2 | 1.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 1.9 | GO:0032355 | response to estradiol(GO:0032355) |
0.2 | 33.0 | GO:0006397 | mRNA processing(GO:0006397) |
0.2 | 2.2 | GO:0045214 | sarcomere organization(GO:0045214) |
0.2 | 0.6 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 0.2 | GO:0002434 | immune complex clearance(GO:0002434) |
0.2 | 1.3 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.2 | 1.6 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.2 | 0.5 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.2 | 0.7 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 22.8 | GO:0006281 | DNA repair(GO:0006281) |
0.2 | 0.4 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.2 | 0.7 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.2 | 0.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 0.9 | GO:0051193 | regulation of cofactor metabolic process(GO:0051193) |
0.2 | 0.5 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.2 | 0.5 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.2 | 3.2 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.2 | 0.2 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.2 | 0.2 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 0.9 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.2 | 0.7 | GO:0051181 | cofactor transport(GO:0051181) |
0.2 | 0.3 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 0.2 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.2 | 2.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.2 | 0.5 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.2 | 15.4 | GO:0018105 | peptidyl-serine phosphorylation(GO:0018105) |
0.2 | 0.2 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.2 | 1.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 0.3 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.2 | 0.7 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 0.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.2 | 0.7 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.2 | 3.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.2 | 21.1 | GO:0051260 | protein homooligomerization(GO:0051260) |
0.2 | 0.2 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
0.2 | 0.7 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 0.2 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.2 | 2.2 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.2 | 1.7 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.2 | 0.3 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.2 | 0.2 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.2 | 1.0 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.2 | 0.2 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 5.3 | GO:0006457 | protein folding(GO:0006457) |
0.2 | 0.2 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.2 | 0.7 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.2 | 0.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 0.3 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 1.1 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 0.3 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 0.6 | GO:1901660 | calcium ion export(GO:1901660) |
0.2 | 0.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.2 | 0.2 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 3.9 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 0.2 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.2 | 1.4 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.2 | 0.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 0.3 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 0.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.2 | 2.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 1.4 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.2 | 0.3 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.2 | 1.5 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.2 | 0.9 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.2 | 3.5 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.2 | 1.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.2 | 0.3 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.2 | 0.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.2 | 10.4 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.1 | 0.4 | GO:0000910 | cytokinesis(GO:0000910) |
0.1 | 3.1 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.1 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.1 | 0.7 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.1 | 1.9 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 3.9 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.1 | 0.3 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 1.0 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.3 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.1 | 0.3 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 1.8 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.1 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.1 | 0.1 | GO:0033131 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 1.7 | GO:0072331 | signal transduction by p53 class mediator(GO:0072331) |
0.1 | 0.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 2.8 | GO:0090174 | organelle membrane fusion(GO:0090174) |
0.1 | 0.6 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.7 | GO:0031529 | ruffle organization(GO:0031529) |
0.1 | 1.0 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 0.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.7 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.4 | GO:0072378 | blood coagulation, intrinsic pathway(GO:0007597) blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 0.1 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.1 | 1.6 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.1 | 0.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.5 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.1 | GO:0014075 | response to amphetamine(GO:0001975) response to amine(GO:0014075) |
0.1 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.4 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.1 | 1.4 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.3 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
0.1 | 0.4 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.3 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.1 | 0.3 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.8 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.3 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.8 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.3 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.9 | GO:0031396 | regulation of protein ubiquitination(GO:0031396) |
0.1 | 1.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 1.0 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.3 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 17.8 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.1 | 0.5 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.6 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.1 | 0.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.1 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.1 | 0.2 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.1 | 0.4 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.1 | 0.4 | GO:0015677 | copper ion import(GO:0015677) ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.1 | 0.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.2 | GO:0070570 | regulation of neuron projection regeneration(GO:0070570) |
0.1 | 0.8 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.1 | 1.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.1 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.1 | 0.4 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.5 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
0.1 | 0.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 4.2 | GO:0006821 | chloride transport(GO:0006821) |
0.1 | 0.6 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.7 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.1 | 0.1 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.1 | 0.8 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.1 | 0.2 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 1.1 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
0.1 | 0.3 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 0.1 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.1 | 0.4 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.1 | 1.1 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.1 | GO:1900094 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.1 | 0.3 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.1 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.3 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.8 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.3 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.1 | 0.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 2.4 | GO:0007005 | mitochondrion organization(GO:0007005) |
0.1 | 0.3 | GO:0001935 | endothelial cell proliferation(GO:0001935) |
0.1 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 7.7 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.1 | 3.6 | GO:0008154 | actin polymerization or depolymerization(GO:0008154) |
0.1 | 0.2 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.4 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 1.8 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 19.2 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.1 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.1 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.1 | 1.0 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.2 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.1 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 0.2 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 0.3 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.1 | 0.1 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.1 | 0.3 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.3 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.1 | 0.5 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 0.2 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.1 | 0.2 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 0.1 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.1 | 0.1 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.1 | 0.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 1.8 | GO:0006260 | DNA replication(GO:0006260) |
0.1 | 3.2 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.1 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 1.0 | GO:0009408 | response to heat(GO:0009408) |
0.1 | 0.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.2 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.1 | 0.4 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.2 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.1 | 4.8 | GO:1903008 | organelle disassembly(GO:1903008) |
0.1 | 0.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.3 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 0.1 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.1 | 0.9 | GO:0097202 | activation of cysteine-type endopeptidase activity(GO:0097202) |
0.1 | 0.1 | GO:0031100 | organ regeneration(GO:0031100) |
0.1 | 0.1 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.1 | 1.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.4 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.2 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.1 | 0.1 | GO:0060746 | parental behavior(GO:0060746) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.7 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 0.1 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.1 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.2 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 2.9 | GO:0006979 | response to oxidative stress(GO:0006979) |
0.1 | 0.8 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.5 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.1 | 0.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.9 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.3 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.7 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.4 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.1 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 0.1 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.1 | 0.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.2 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 4.6 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 0.1 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.1 | 0.3 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.1 | 0.1 | GO:0018209 | peptidyl-serine modification(GO:0018209) |
0.1 | 0.1 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.2 | GO:0010665 | regulation of cardiac muscle cell apoptotic process(GO:0010665) |
0.1 | 0.1 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.1 | 0.4 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.1 | 0.4 | GO:0051262 | protein tetramerization(GO:0051262) |
0.1 | 0.5 | GO:0097009 | energy homeostasis(GO:0097009) |
0.1 | 0.1 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.7 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.1 | 0.3 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.0 | 0.4 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.1 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.1 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.4 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.0 | 0.0 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.1 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.0 | 0.2 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 0.0 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.0 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.7 | GO:0050818 | regulation of coagulation(GO:0050818) |
0.0 | 0.7 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.1 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.0 | 0.4 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.2 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.0 | 0.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.0 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 0.0 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.0 | 0.0 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.0 | 0.0 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.0 | 0.1 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.0 | 0.2 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.0 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.3 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.2 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.0 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.0 | 0.2 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.0 | 0.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.4 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.1 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.0 | 0.2 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.1 | GO:0043486 | histone exchange(GO:0043486) |
0.0 | 0.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.0 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.2 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.0 | 0.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.0 | GO:0015872 | dopamine transport(GO:0015872) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.0 | GO:0072539 | T-helper 17 type immune response(GO:0072538) T-helper 17 cell differentiation(GO:0072539) |
0.0 | 0.0 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.0 | 0.0 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.2 | GO:0006024 | glycosaminoglycan biosynthetic process(GO:0006024) |
0.0 | 0.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.0 | GO:0097300 | programmed necrotic cell death(GO:0097300) |
0.0 | 0.0 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.0 | 0.0 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.2 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.0 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.0 | 0.1 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.2 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.0 | GO:0033574 | response to testosterone(GO:0033574) |
0.0 | 0.0 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.1 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.0 | 0.0 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.0 | 0.0 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.0 | 0.0 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.1 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 8.9 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
2.6 | 7.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
2.2 | 6.7 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
2.1 | 2.1 | GO:0045177 | apical part of cell(GO:0045177) |
2.1 | 6.3 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
2.0 | 12.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
2.0 | 9.8 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
1.9 | 5.8 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
1.9 | 5.6 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.8 | 5.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
1.8 | 5.5 | GO:1990393 | 3M complex(GO:1990393) |
1.7 | 1.7 | GO:0000811 | GINS complex(GO:0000811) |
1.6 | 4.8 | GO:0031084 | BLOC-2 complex(GO:0031084) |
1.5 | 4.4 | GO:0044393 | microspike(GO:0044393) |
1.5 | 5.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
1.5 | 4.4 | GO:0071942 | XPC complex(GO:0071942) |
1.4 | 4.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
1.4 | 7.0 | GO:0030870 | Mre11 complex(GO:0030870) |
1.4 | 4.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
1.4 | 5.5 | GO:0071797 | LUBAC complex(GO:0071797) |
1.4 | 9.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.4 | 9.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.4 | 5.4 | GO:0071817 | MMXD complex(GO:0071817) |
1.3 | 1.3 | GO:0033268 | node of Ranvier(GO:0033268) |
1.3 | 10.6 | GO:0032300 | mismatch repair complex(GO:0032300) |
1.3 | 5.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
1.3 | 9.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.3 | 3.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.3 | 9.0 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
1.3 | 6.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
1.3 | 3.8 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.3 | 3.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.3 | 5.0 | GO:0044308 | axonal spine(GO:0044308) |
1.3 | 3.8 | GO:1990462 | omegasome(GO:1990462) |
1.2 | 4.9 | GO:0045298 | tubulin complex(GO:0045298) |
1.2 | 4.9 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.2 | 3.5 | GO:0097443 | sorting endosome(GO:0097443) |
1.2 | 2.3 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.1 | 12.6 | GO:0005675 | holo TFIIH complex(GO:0005675) |
1.1 | 9.1 | GO:0042587 | glycogen granule(GO:0042587) |
1.1 | 9.1 | GO:0034464 | BBSome(GO:0034464) |
1.1 | 5.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.1 | 14.7 | GO:0036038 | MKS complex(GO:0036038) |
1.1 | 3.4 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.1 | 3.3 | GO:0030673 | axolemma(GO:0030673) |
1.1 | 7.7 | GO:0030008 | TRAPP complex(GO:0030008) |
1.1 | 9.9 | GO:0097470 | ribbon synapse(GO:0097470) |
1.1 | 14.2 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
1.1 | 3.2 | GO:0043293 | apoptosome(GO:0043293) |
1.1 | 7.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
1.1 | 3.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
1.1 | 3.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.1 | 3.2 | GO:0031417 | NatC complex(GO:0031417) |
1.0 | 5.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.0 | 9.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
1.0 | 4.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.0 | 5.1 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.0 | 1.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.0 | 2.0 | GO:0097513 | myosin II filament(GO:0097513) |
1.0 | 6.0 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
1.0 | 4.0 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.0 | 5.9 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
1.0 | 4.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.0 | 5.8 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.0 | 2.9 | GO:0031523 | Myb complex(GO:0031523) |
1.0 | 3.8 | GO:0070876 | SOSS complex(GO:0070876) |
1.0 | 5.7 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
1.0 | 3.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.9 | 7.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.9 | 2.8 | GO:0032280 | symmetric synapse(GO:0032280) |
0.9 | 2.8 | GO:0097441 | basilar dendrite(GO:0097441) |
0.9 | 3.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.9 | 16.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.9 | 5.6 | GO:0097342 | ripoptosome(GO:0097342) |
0.9 | 32.3 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.9 | 5.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.9 | 14.6 | GO:0005682 | U5 snRNP(GO:0005682) |
0.9 | 4.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.9 | 3.6 | GO:0030478 | actin cap(GO:0030478) |
0.9 | 3.6 | GO:0042583 | chromaffin granule(GO:0042583) |
0.9 | 2.7 | GO:0042585 | germinal vesicle(GO:0042585) |
0.9 | 0.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.9 | 7.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.9 | 9.7 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.9 | 9.7 | GO:0042555 | MCM complex(GO:0042555) |
0.9 | 0.9 | GO:0030135 | coated vesicle(GO:0030135) |
0.9 | 2.6 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.9 | 2.6 | GO:0005745 | m-AAA complex(GO:0005745) |
0.9 | 5.1 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.9 | 4.3 | GO:0070187 | telosome(GO:0070187) |
0.9 | 3.4 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.8 | 0.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.8 | 17.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.8 | 15.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.8 | 5.0 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.8 | 4.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.8 | 12.4 | GO:0031082 | BLOC complex(GO:0031082) |
0.8 | 11.6 | GO:0031011 | Ino80 complex(GO:0031011) |
0.8 | 4.9 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.8 | 21.2 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.8 | 2.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.8 | 8.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.8 | 5.6 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.8 | 14.4 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.8 | 1.6 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.8 | 1.6 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.8 | 4.0 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.8 | 12.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.8 | 3.1 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.8 | 3.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.8 | 17.6 | GO:0030686 | 90S preribosome(GO:0030686) |
0.8 | 30.3 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.8 | 1.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.8 | 5.3 | GO:0005688 | U6 snRNP(GO:0005688) |
0.8 | 0.8 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.8 | 4.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.8 | 9.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.7 | 10.5 | GO:0030914 | STAGA complex(GO:0030914) |
0.7 | 5.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.7 | 8.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.7 | 15.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.7 | 0.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.7 | 6.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.7 | 2.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.7 | 6.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.7 | 3.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.7 | 2.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.7 | 0.7 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.7 | 2.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.7 | 3.6 | GO:0002177 | manchette(GO:0002177) |
0.7 | 2.8 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.7 | 5.6 | GO:0031252 | cell leading edge(GO:0031252) |
0.7 | 2.8 | GO:0000322 | storage vacuole(GO:0000322) |
0.7 | 2.8 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.7 | 0.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.7 | 0.7 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.7 | 2.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.7 | 2.7 | GO:0000235 | astral microtubule(GO:0000235) |
0.7 | 14.9 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.7 | 29.0 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.7 | 2.7 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.7 | 2.7 | GO:0071203 | WASH complex(GO:0071203) |
0.7 | 0.7 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.7 | 12.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.7 | 2.6 | GO:0000938 | GARP complex(GO:0000938) |
0.7 | 7.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.7 | 1.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.7 | 12.4 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.7 | 2.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.7 | 2.6 | GO:0032021 | NELF complex(GO:0032021) |
0.7 | 9.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.6 | 2.6 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.6 | 7.0 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.6 | 1.9 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.6 | 7.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.6 | 2.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.6 | 31.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.6 | 6.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.6 | 18.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.6 | 8.8 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.6 | 0.6 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.6 | 8.7 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.6 | 5.0 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.6 | 1.9 | GO:0005683 | U7 snRNP(GO:0005683) |
0.6 | 1.9 | GO:0061574 | ASAP complex(GO:0061574) |
0.6 | 0.6 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.6 | 3.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.6 | 1.8 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.6 | 7.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.6 | 4.9 | GO:0000124 | SAGA complex(GO:0000124) |
0.6 | 1.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.6 | 1.8 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.6 | 0.6 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.6 | 7.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.6 | 0.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.6 | 1.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.6 | 6.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.6 | 3.6 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.6 | 1.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.6 | 11.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.6 | 2.4 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.6 | 1.8 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.6 | 5.9 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.6 | 1.8 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.6 | 0.6 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.6 | 1.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.6 | 5.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.6 | 4.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.6 | 0.6 | GO:0097413 | Lewy body(GO:0097413) |
0.6 | 6.3 | GO:0001527 | microfibril(GO:0001527) |
0.6 | 1.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.6 | 3.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.6 | 15.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.6 | 6.8 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.6 | 3.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.6 | 6.7 | GO:0000800 | lateral element(GO:0000800) |
0.6 | 4.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.6 | 3.9 | GO:0005869 | dynactin complex(GO:0005869) |
0.6 | 1.7 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.6 | 1.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.6 | 7.7 | GO:0032040 | small-subunit processome(GO:0032040) |
0.6 | 6.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.5 | 6.6 | GO:0097546 | ciliary base(GO:0097546) |
0.5 | 4.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.5 | 4.3 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.5 | 2.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.5 | 2.2 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.5 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.5 | 1.6 | GO:0043511 | inhibin complex(GO:0043511) |
0.5 | 21.4 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.5 | 37.4 | GO:0005814 | centriole(GO:0005814) |
0.5 | 10.0 | GO:0005839 | proteasome core complex(GO:0005839) |
0.5 | 1.6 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.5 | 1.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.5 | 6.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.5 | 2.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.5 | 11.8 | GO:0044295 | axonal growth cone(GO:0044295) |
0.5 | 0.5 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.5 | 7.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.5 | 1.0 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.5 | 1.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.5 | 1.0 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.5 | 7.5 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.5 | 3.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.5 | 0.5 | GO:0000125 | PCAF complex(GO:0000125) |
0.5 | 1.0 | GO:0071564 | npBAF complex(GO:0071564) |
0.5 | 7.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.5 | 2.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.5 | 8.7 | GO:0016607 | nuclear speck(GO:0016607) |
0.5 | 3.4 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.5 | 3.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.5 | 2.9 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.5 | 31.2 | GO:0000776 | kinetochore(GO:0000776) |
0.5 | 1.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.5 | 1.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.5 | 24.6 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.5 | 2.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.5 | 1.9 | GO:0097422 | tubular endosome(GO:0097422) |
0.5 | 0.9 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.5 | 1.4 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.5 | 2.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 1.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.5 | 1.4 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.5 | 3.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.5 | 1.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.5 | 39.8 | GO:0044309 | neuron spine(GO:0044309) |
0.5 | 2.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.5 | 8.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.5 | 0.9 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.5 | 0.9 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.5 | 0.9 | GO:0005955 | calcineurin complex(GO:0005955) |
0.5 | 1.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.5 | 20.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.5 | 3.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.5 | 6.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.4 | 4.5 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.4 | 1.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.4 | 1.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.4 | 2.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.4 | 4.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.4 | 1.8 | GO:0097449 | astrocyte projection(GO:0097449) |
0.4 | 3.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.4 | 0.9 | GO:1990635 | proximal dendrite(GO:1990635) |
0.4 | 90.8 | GO:0005813 | centrosome(GO:0005813) |
0.4 | 4.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.4 | 16.4 | GO:0031201 | SNARE complex(GO:0031201) |
0.4 | 2.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.4 | 3.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.4 | 2.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 2.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 8.8 | GO:0015030 | Cajal body(GO:0015030) |
0.4 | 2.6 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.4 | 1.7 | GO:0042825 | TAP complex(GO:0042825) |
0.4 | 2.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.4 | 7.8 | GO:0031902 | late endosome membrane(GO:0031902) |
0.4 | 1.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.4 | 0.9 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.4 | 3.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.4 | 21.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.4 | 10.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.4 | 1.7 | GO:0030894 | replisome(GO:0030894) |
0.4 | 0.4 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.4 | 28.5 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.4 | 3.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.4 | 1.7 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.4 | 0.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.4 | 4.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.4 | 0.4 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.4 | 2.0 | GO:0071439 | clathrin complex(GO:0071439) |
0.4 | 1.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 1.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.4 | 3.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.4 | 2.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.4 | 7.2 | GO:0005657 | replication fork(GO:0005657) |
0.4 | 1.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 2.0 | GO:0033263 | CORVET complex(GO:0033263) |
0.4 | 3.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.4 | 2.8 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.4 | 0.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.4 | 9.5 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.4 | 0.4 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.4 | 3.5 | GO:0060076 | excitatory synapse(GO:0060076) |
0.4 | 0.4 | GO:0005818 | aster(GO:0005818) |
0.4 | 10.5 | GO:0032420 | stereocilium(GO:0032420) |
0.4 | 4.3 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.4 | 0.8 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 1.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.4 | 3.8 | GO:0030904 | retromer complex(GO:0030904) |
0.4 | 1.9 | GO:0070852 | cell body fiber(GO:0070852) |
0.4 | 1.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.4 | 43.7 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.4 | 0.4 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.4 | 1.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.4 | 3.8 | GO:0032039 | integrator complex(GO:0032039) |
0.4 | 2.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.4 | 169.8 | GO:0005730 | nucleolus(GO:0005730) |
0.4 | 5.7 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.4 | 1.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.4 | 1.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.4 | 0.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.4 | 411.1 | GO:0005739 | mitochondrion(GO:0005739) |
0.4 | 1.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.4 | 1.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.4 | 1.1 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.4 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 2.5 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.4 | 8.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.4 | 1.1 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.4 | 0.4 | GO:0070695 | FHF complex(GO:0070695) |
0.4 | 6.1 | GO:0055037 | recycling endosome(GO:0055037) |
0.4 | 4.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.4 | 1.4 | GO:0031672 | A band(GO:0031672) |
0.3 | 2.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 1.4 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.3 | 2.1 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.3 | 3.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 1.0 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.3 | 3.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.3 | 3.7 | GO:0016605 | PML body(GO:0016605) |
0.3 | 0.7 | GO:0005883 | neurofilament(GO:0005883) |
0.3 | 1.0 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.3 | 10.5 | GO:0005811 | lipid particle(GO:0005811) |
0.3 | 5.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.3 | 1.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.3 | 2.3 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.3 | 0.6 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.3 | 16.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 1.0 | GO:0031415 | NatA complex(GO:0031415) |
0.3 | 25.1 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.3 | 2.5 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.3 | 3.7 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 0.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.3 | 1.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.3 | 1.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.3 | 4.5 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.3 | 3.6 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 9.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.3 | 0.3 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.3 | 4.8 | GO:0034704 | calcium channel complex(GO:0034704) |
0.3 | 0.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.3 | 0.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.3 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 0.6 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.3 | 3.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.3 | 3.2 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.3 | 1.2 | GO:0071547 | piP-body(GO:0071547) |
0.3 | 4.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 3.8 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 0.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.3 | 3.1 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.3 | 7.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.3 | 3.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 1.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.3 | 0.8 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.3 | 1.1 | GO:0034709 | methylosome(GO:0034709) |
0.3 | 2.2 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 1.4 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.3 | 0.8 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.3 | 3.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.3 | 0.5 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.3 | 0.8 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 0.3 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 0.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 1.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 0.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 1.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.3 | 18.4 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.3 | 2.4 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.3 | 1.0 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.3 | 0.5 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.3 | 57.3 | GO:0044432 | endoplasmic reticulum part(GO:0044432) |
0.3 | 9.4 | GO:0005643 | nuclear pore(GO:0005643) |
0.3 | 3.3 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 39.1 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 16.9 | GO:0043209 | myelin sheath(GO:0043209) |
0.2 | 0.7 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 5.9 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.2 | 7.4 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 2.7 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 1.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 1.2 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.2 | 1.7 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 5.9 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.2 | 4.0 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 1.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 3.4 | GO:0044298 | cell body membrane(GO:0044298) |
0.2 | 10.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 18.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 4.3 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 1.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 5.5 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 1.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 1.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 1.9 | GO:0005840 | ribosome(GO:0005840) |
0.2 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 6.1 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 0.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 5.8 | GO:0005819 | spindle(GO:0005819) |
0.2 | 18.2 | GO:0005769 | early endosome(GO:0005769) |
0.2 | 1.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 4.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 0.2 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.2 | 14.2 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 0.4 | GO:0042611 | MHC protein complex(GO:0042611) |
0.2 | 11.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 3.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 1.7 | GO:0030496 | midbody(GO:0030496) |
0.2 | 0.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 110.0 | GO:0005829 | cytosol(GO:0005829) |
0.2 | 4.6 | GO:0031090 | organelle membrane(GO:0031090) |
0.2 | 6.5 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 1.1 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.2 | 0.7 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 2.4 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 0.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 1.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 0.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 2.1 | GO:0005901 | caveola(GO:0005901) |
0.2 | 0.3 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.2 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 1.6 | GO:0005635 | nuclear envelope(GO:0005635) |
0.2 | 22.0 | GO:0005929 | cilium(GO:0005929) |
0.2 | 0.9 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 1.2 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 0.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 1.1 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.2 | 0.8 | GO:1990391 | DNA repair complex(GO:1990391) |
0.2 | 7.2 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 15.8 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.1 | 78.6 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 4.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.6 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.7 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 1.0 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 1.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 8.2 | GO:0030425 | dendrite(GO:0030425) |
0.1 | 382.6 | GO:0005737 | cytoplasm(GO:0005737) |
0.1 | 0.3 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 6.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.4 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 12.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 1.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.2 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 41.1 | GO:0043230 | extracellular organelle(GO:0043230) |
0.1 | 1.0 | GO:0012505 | endomembrane system(GO:0012505) |
0.1 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 182.9 | GO:0016020 | membrane(GO:0016020) |
0.1 | 1.7 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.2 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.0 | 0.5 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.0 | GO:0097346 | INO80-type complex(GO:0097346) |
0.0 | 0.0 | GO:0005902 | microvillus(GO:0005902) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 9.0 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.7 | 8.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
2.6 | 7.7 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
2.6 | 7.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
2.6 | 7.7 | GO:0032142 | single guanine insertion binding(GO:0032142) |
2.4 | 9.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
2.2 | 6.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
2.2 | 2.2 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
2.0 | 6.0 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
2.0 | 2.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.9 | 17.4 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.9 | 5.6 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
1.8 | 7.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
1.7 | 8.6 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
1.6 | 4.9 | GO:0089720 | caspase binding(GO:0089720) |
1.6 | 9.8 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
1.6 | 4.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
1.6 | 4.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.5 | 4.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.5 | 1.5 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
1.5 | 1.5 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
1.4 | 11.6 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
1.4 | 5.6 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
1.4 | 4.2 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
1.3 | 4.0 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
1.3 | 5.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
1.3 | 4.0 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
1.3 | 5.3 | GO:0097001 | ceramide binding(GO:0097001) |
1.3 | 5.2 | GO:0030371 | translation repressor activity(GO:0030371) |
1.3 | 3.9 | GO:0043398 | HLH domain binding(GO:0043398) |
1.3 | 3.8 | GO:0004946 | bombesin receptor activity(GO:0004946) |
1.2 | 8.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
1.2 | 3.6 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
1.2 | 1.2 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
1.2 | 3.6 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
1.2 | 4.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.2 | 22.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
1.2 | 5.9 | GO:0052759 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
1.2 | 4.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
1.2 | 1.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.2 | 11.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.2 | 2.3 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
1.2 | 1.2 | GO:0008425 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
1.2 | 3.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
1.1 | 3.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
1.1 | 2.3 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
1.1 | 3.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.1 | 4.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.1 | 4.5 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.1 | 2.2 | GO:0002134 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
1.1 | 3.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.1 | 3.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.1 | 5.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.1 | 2.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.1 | 2.2 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
1.1 | 4.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.1 | 4.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.1 | 7.5 | GO:0000150 | recombinase activity(GO:0000150) |
1.1 | 4.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.1 | 7.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.1 | 20.1 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
1.1 | 3.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
1.1 | 4.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
1.1 | 1.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
1.1 | 6.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
1.0 | 8.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
1.0 | 1.0 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.0 | 4.1 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
1.0 | 5.1 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
1.0 | 25.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.0 | 4.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.0 | 5.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
1.0 | 2.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.0 | 3.0 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.0 | 2.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.0 | 3.0 | GO:0097016 | L27 domain binding(GO:0097016) |
1.0 | 2.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.0 | 4.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
1.0 | 1.9 | GO:0000403 | Y-form DNA binding(GO:0000403) |
1.0 | 1.9 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.0 | 4.8 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
1.0 | 2.9 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
1.0 | 4.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.0 | 3.8 | GO:0004370 | glycerol kinase activity(GO:0004370) |
1.0 | 5.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.0 | 6.7 | GO:0080014 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
1.0 | 7.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
1.0 | 3.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.9 | 7.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.9 | 10.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.9 | 2.8 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.9 | 2.8 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.9 | 5.6 | GO:0015288 | porin activity(GO:0015288) |
0.9 | 8.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.9 | 16.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.9 | 4.7 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.9 | 3.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.9 | 4.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.9 | 3.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.9 | 2.8 | GO:0019961 | interferon binding(GO:0019961) |
0.9 | 3.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.9 | 4.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.9 | 6.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.9 | 2.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.9 | 3.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.9 | 8.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.9 | 4.5 | GO:0070061 | fructose binding(GO:0070061) |
0.9 | 0.9 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.9 | 2.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.9 | 2.7 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.9 | 19.6 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.9 | 0.9 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.9 | 26.6 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.9 | 2.7 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.9 | 2.6 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.9 | 4.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.9 | 19.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.9 | 14.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.9 | 2.6 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.9 | 1.7 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.9 | 2.6 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.9 | 17.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.9 | 15.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.9 | 4.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.9 | 2.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.8 | 0.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.8 | 1.7 | GO:0070538 | oleic acid binding(GO:0070538) |
0.8 | 5.9 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.8 | 7.5 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.8 | 0.8 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.8 | 3.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.8 | 2.5 | GO:0035939 | microsatellite binding(GO:0035939) |
0.8 | 0.8 | GO:0030487 | inositol-4,5-bisphosphate 5-phosphatase activity(GO:0030487) |
0.8 | 2.5 | GO:0071253 | connexin binding(GO:0071253) |
0.8 | 2.4 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.8 | 3.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.8 | 8.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.8 | 6.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.8 | 8.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.8 | 9.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.8 | 1.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.8 | 4.8 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.8 | 6.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.8 | 5.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.8 | 3.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.8 | 2.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.8 | 1.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.8 | 9.4 | GO:0070402 | NADPH binding(GO:0070402) |
0.8 | 0.8 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.8 | 3.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.8 | 7.8 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.8 | 2.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.8 | 3.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.8 | 2.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.8 | 3.8 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.8 | 0.8 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.8 | 3.8 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.8 | 0.8 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.8 | 0.8 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.8 | 2.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.8 | 6.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.8 | 3.8 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.8 | 7.6 | GO:0070403 | NAD+ binding(GO:0070403) |
0.8 | 4.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.8 | 3.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.8 | 2.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.7 | 2.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.7 | 2.9 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.7 | 4.4 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.7 | 3.7 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.7 | 2.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.7 | 2.9 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.7 | 2.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.7 | 3.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.7 | 2.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.7 | 2.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.7 | 3.6 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.7 | 2.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.7 | 7.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.7 | 2.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.7 | 0.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.7 | 1.4 | GO:0030984 | kininogen binding(GO:0030984) |
0.7 | 4.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.7 | 3.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.7 | 2.8 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.7 | 4.9 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.7 | 2.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.7 | 2.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.7 | 2.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.7 | 14.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.7 | 4.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.7 | 0.7 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
0.7 | 1.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.7 | 2.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.7 | 4.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.7 | 4.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.7 | 1.4 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.7 | 3.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.7 | 7.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.7 | 8.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.7 | 2.7 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.7 | 40.0 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.7 | 4.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.7 | 15.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.7 | 2.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.7 | 0.7 | GO:0016895 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
0.7 | 5.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.7 | 5.3 | GO:0034784 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.7 | 21.8 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.7 | 3.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.7 | 3.9 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.7 | 3.9 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.7 | 3.9 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.7 | 4.6 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.7 | 2.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.6 | 0.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.6 | 2.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.6 | 20.0 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.6 | 1.9 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.6 | 10.9 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.6 | 3.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.6 | 1.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.6 | 0.6 | GO:0086056 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.6 | 2.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.6 | 1.9 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.6 | 1.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.6 | 7.6 | GO:0005521 | lamin binding(GO:0005521) |
0.6 | 4.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.6 | 10.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.6 | 3.1 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.6 | 1.9 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.6 | 5.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.6 | 1.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.6 | 3.1 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.6 | 4.3 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.6 | 3.7 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.6 | 8.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.6 | 9.2 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.6 | 4.3 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.6 | 3.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.6 | 20.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.6 | 14.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.6 | 3.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.6 | 3.6 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.6 | 1.8 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.6 | 3.0 | GO:0031432 | titin binding(GO:0031432) |
0.6 | 1.8 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.6 | 1.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.6 | 9.6 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.6 | 3.6 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.6 | 1.8 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.6 | 5.4 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.6 | 0.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.6 | 2.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.6 | 3.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.6 | 1.2 | GO:0016595 | glutamate binding(GO:0016595) |
0.6 | 3.0 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.6 | 0.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.6 | 4.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.6 | 4.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.6 | 1.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.6 | 5.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.6 | 2.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.6 | 0.6 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.6 | 1.7 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.6 | 4.0 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.6 | 3.5 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.6 | 1.7 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.6 | 2.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.6 | 4.0 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.6 | 1.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.6 | 2.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.6 | 1.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.6 | 2.8 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.6 | 1.7 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.6 | 3.9 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.6 | 2.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.6 | 3.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.6 | 4.5 | GO:0070628 | proteasome binding(GO:0070628) |
0.6 | 2.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.6 | 0.6 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.6 | 7.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.6 | 1.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.6 | 5.6 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.5 | 4.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.5 | 1.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.5 | 3.3 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.5 | 4.9 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.5 | 1.1 | GO:2001070 | starch binding(GO:2001070) |
0.5 | 100.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.5 | 2.2 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.5 | 3.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.5 | 1.1 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.5 | 1.6 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.5 | 11.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.5 | 3.2 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.5 | 1.6 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.5 | 15.4 | GO:0000049 | tRNA binding(GO:0000049) |
0.5 | 1.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.5 | 1.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.5 | 1.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.5 | 2.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.5 | 7.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.5 | 0.5 | GO:0031013 | troponin I binding(GO:0031013) |
0.5 | 4.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.5 | 2.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.5 | 1.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.5 | 2.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.5 | 3.6 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.5 | 1.0 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.5 | 2.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.5 | 0.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.5 | 1.5 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.5 | 42.7 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.5 | 20.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.5 | 20.0 | GO:0043022 | ribosome binding(GO:0043022) |
0.5 | 2.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.5 | 1.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.5 | 3.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.5 | 4.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.5 | 9.6 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.5 | 28.3 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.5 | 11.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.5 | 2.5 | GO:0034046 | poly(G) binding(GO:0034046) |
0.5 | 6.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.5 | 2.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.5 | 1.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.5 | 0.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.5 | 2.0 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.5 | 12.9 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.5 | 0.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.5 | 0.5 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.5 | 10.3 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.5 | 1.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.5 | 1.5 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.5 | 1.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.5 | 9.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.5 | 4.4 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
0.5 | 2.4 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.5 | 5.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.5 | 10.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.5 | 1.5 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.5 | 1.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.5 | 0.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.5 | 1.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.5 | 1.0 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.5 | 1.4 | GO:0004096 | catalase activity(GO:0004096) |
0.5 | 0.5 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.5 | 1.0 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.5 | 2.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.5 | 2.4 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.5 | 9.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.5 | 1.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.5 | 1.4 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.5 | 5.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.5 | 1.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.5 | 2.8 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.5 | 1.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.5 | 1.4 | GO:0030172 | troponin C binding(GO:0030172) |
0.5 | 8.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.5 | 3.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.5 | 3.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.5 | 1.9 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.5 | 1.4 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.5 | 2.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.5 | 4.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.5 | 0.9 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.5 | 3.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.5 | 6.5 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.5 | 1.9 | GO:0043426 | MRF binding(GO:0043426) |
0.5 | 13.9 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.5 | 0.5 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.5 | 4.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.5 | 1.8 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.5 | 2.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.5 | 13.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.5 | 2.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.5 | 2.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.5 | 2.3 | GO:0005522 | profilin binding(GO:0005522) |
0.5 | 1.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.5 | 0.5 | GO:0051373 | FATZ binding(GO:0051373) |
0.5 | 1.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.5 | 1.8 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.4 | 0.9 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.4 | 2.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.4 | 1.3 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.4 | 0.9 | GO:1990188 | euchromatin binding(GO:1990188) |
0.4 | 2.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.4 | 4.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.4 | 2.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.4 | 2.2 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.4 | 2.7 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.4 | 2.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.4 | 0.9 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.4 | 7.1 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.4 | 6.7 | GO:0030515 | snoRNA binding(GO:0030515) |
0.4 | 8.9 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.4 | 5.8 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.4 | 2.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.4 | 1.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 2.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.4 | 0.9 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.4 | 1.3 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.4 | 2.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.4 | 7.0 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.4 | 1.3 | GO:0019003 | GDP binding(GO:0019003) |
0.4 | 1.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.4 | 0.4 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.4 | 1.3 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.4 | 0.9 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.4 | 6.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.4 | 2.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.4 | 3.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.4 | 1.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.4 | 1.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.4 | 3.4 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.4 | 4.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.4 | 4.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.4 | 5.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.4 | 1.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.4 | 2.5 | GO:0030276 | clathrin binding(GO:0030276) |
0.4 | 2.9 | GO:0098988 | glutamate receptor activity(GO:0008066) G-protein coupled glutamate receptor activity(GO:0098988) |
0.4 | 3.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.4 | 2.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 0.8 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.4 | 4.6 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.4 | 0.8 | GO:0042805 | actinin binding(GO:0042805) |
0.4 | 3.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.4 | 5.0 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.4 | 2.9 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.4 | 0.8 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.4 | 1.2 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.4 | 1.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.4 | 0.4 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.4 | 2.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.4 | 1.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.4 | 0.4 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.4 | 2.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.4 | 10.6 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.4 | 1.6 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 4.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.4 | 5.3 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.4 | 1.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 2.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.4 | 21.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 1.6 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.4 | 2.0 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.4 | 0.8 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.4 | 1.6 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.4 | 1.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.4 | 2.8 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.4 | 0.8 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.4 | 1.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.4 | 4.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.4 | 3.9 | GO:0051378 | serotonin binding(GO:0051378) |
0.4 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.4 | 1.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.4 | 2.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.4 | 10.2 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.4 | 2.7 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.4 | 5.5 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.4 | 0.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.4 | 2.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 5.4 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.4 | 0.4 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.4 | 1.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.4 | 5.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.4 | 3.1 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.4 | 1.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.4 | 2.7 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.4 | 3.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.4 | 4.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.4 | 1.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.4 | 5.3 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.4 | 6.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.4 | 15.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.4 | 3.4 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.4 | 2.3 | GO:0018502 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.4 | 3.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.4 | 1.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.4 | 6.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.4 | 3.8 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.4 | 0.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 3.0 | GO:0031386 | protein tag(GO:0031386) |
0.4 | 3.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.4 | 0.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.4 | 1.5 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.4 | 20.5 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.4 | 2.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.4 | 1.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.4 | 0.7 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.4 | 0.7 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.4 | 3.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.4 | 9.9 | GO:0004386 | helicase activity(GO:0004386) |
0.4 | 2.9 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.4 | 1.8 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.4 | 1.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.4 | 0.4 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.4 | 3.3 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.4 | 20.0 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.4 | 2.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 2.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.4 | 1.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 1.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.4 | 7.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.4 | 1.8 | GO:0048038 | quinone binding(GO:0048038) |
0.4 | 1.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.4 | 4.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.4 | 1.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.4 | 2.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.4 | 3.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.4 | 1.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 22.3 | GO:0008565 | protein transporter activity(GO:0008565) |
0.4 | 0.7 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.4 | 0.7 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.4 | 0.4 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 2.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 26.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.3 | 1.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.3 | 1.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 8.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.3 | 1.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.3 | 0.3 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.3 | 0.3 | GO:0045182 | translation regulator activity(GO:0045182) |
0.3 | 1.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 1.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 3.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.3 | 2.4 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.3 | 3.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.3 | 2.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 45.9 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.3 | 2.0 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.3 | 11.4 | GO:0005507 | copper ion binding(GO:0005507) |
0.3 | 1.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 1.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.3 | 2.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 1.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 0.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.3 | 2.0 | GO:0043909 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.3 | 37.8 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.3 | 2.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 1.0 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 1.6 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.3 | 3.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.3 | 1.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.3 | 1.9 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.3 | 1.6 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.3 | 1.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.3 | 3.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.3 | 2.6 | GO:0034918 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.3 | 7.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 4.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 8.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.3 | 1.0 | GO:0048185 | activin binding(GO:0048185) |
0.3 | 0.3 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.3 | 0.3 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.3 | 3.5 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.3 | 1.3 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.3 | 1.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.3 | 3.4 | GO:0031402 | sodium ion binding(GO:0031402) |
0.3 | 1.6 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.3 | 4.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 3.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 0.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 0.9 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.3 | 1.5 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.3 | 0.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 0.6 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 0.9 | GO:0016151 | nickel cation binding(GO:0016151) |
0.3 | 3.7 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 2.4 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.3 | 5.2 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.3 | 3.7 | GO:0051020 | GTPase binding(GO:0051020) |
0.3 | 30.5 | GO:0018169 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.3 | 0.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.3 | 0.6 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.3 | 10.3 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.3 | 1.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 1.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.3 | 3.0 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 18.8 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.3 | 1.5 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.3 | 0.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.3 | 0.6 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.3 | 3.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 1.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.3 | 0.9 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 0.9 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 3.2 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.3 | 5.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.3 | 0.6 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.3 | 0.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 0.3 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 6.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.3 | 7.8 | GO:0015485 | cholesterol binding(GO:0015485) |
0.3 | 4.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 0.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.3 | 12.6 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.3 | 2.9 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.3 | 3.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 1.4 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.3 | 0.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 1.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 2.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 0.8 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 5.1 | GO:0015928 | fucosidase activity(GO:0015928) |
0.3 | 0.3 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.3 | 0.8 | GO:0050543 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.3 | 1.4 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.3 | 1.4 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.3 | 4.1 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.3 | 3.0 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.3 | 1.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.3 | 25.6 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.3 | 2.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 0.5 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.3 | 63.1 | GO:0005525 | GTP binding(GO:0005525) |
0.3 | 2.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 3.2 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.3 | 0.5 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.3 | 0.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.3 | 1.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.3 | 1.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 0.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.3 | 1.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 7.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.3 | 1.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 1.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 1.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.3 | 2.8 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.3 | 4.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.3 | 1.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.3 | 2.6 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.3 | 0.8 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.3 | 2.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.3 | 0.3 | GO:0070905 | serine binding(GO:0070905) |
0.3 | 1.0 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.2 | 21.2 | GO:0008017 | microtubule binding(GO:0008017) |
0.2 | 134.8 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.2 | 0.7 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.2 | 1.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 14.4 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.2 | 9.0 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.2 | 1.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 6.0 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.2 | 1.9 | GO:0001968 | fibronectin binding(GO:0001968) |
0.2 | 0.7 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 0.7 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 5.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 0.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 4.2 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.2 | 0.5 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 0.5 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.2 | 0.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 20.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 3.0 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.2 | 0.2 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.2 | 0.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.2 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
0.2 | 9.2 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.2 | 0.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 2.0 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.2 | 0.7 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.2 | 2.5 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 2.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 0.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 0.2 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.2 | 3.0 | GO:0015631 | tubulin binding(GO:0015631) |
0.2 | 0.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 0.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 5.5 | GO:0035064 | methylated histone binding(GO:0035064) |
0.2 | 1.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 2.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 0.6 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 28.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 1.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 3.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 0.8 | GO:0005048 | signal sequence binding(GO:0005048) |
0.2 | 0.8 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 0.4 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 7.1 | GO:0005516 | calmodulin binding(GO:0005516) |
0.2 | 1.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 1.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 38.8 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.2 | 1.8 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.2 | 0.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 4.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 0.8 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 4.4 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.2 | 3.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 5.3 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 0.8 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 0.2 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.2 | 1.6 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 0.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 1.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 1.0 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.2 | 8.2 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.2 | 8.4 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.2 | 0.4 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 0.2 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 0.8 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.2 | 0.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 0.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.7 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 0.9 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.2 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.2 | 0.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.2 | 0.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.9 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 1.6 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 1.4 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.2 | 0.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 0.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 0.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.2 | 0.3 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.2 | 7.3 | GO:0019905 | syntaxin binding(GO:0019905) |
0.2 | 0.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 1.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 2.2 | GO:0004519 | endonuclease activity(GO:0004519) |
0.2 | 3.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 1.0 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 0.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 2.5 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 0.3 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 3.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 0.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 3.0 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.2 | 0.5 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.2 | 0.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 0.8 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 0.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 4.0 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.2 | 0.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 0.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 0.3 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.2 | 1.3 | GO:0000149 | SNARE binding(GO:0000149) |
0.2 | 0.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 0.6 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 0.5 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.2 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 0.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.2 | 26.8 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 2.7 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 0.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 2.1 | GO:0019209 | kinase activator activity(GO:0019209) |
0.1 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 1.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.6 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.1 | 0.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 6.7 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.4 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.8 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 1.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.4 | GO:0016405 | CoA-ligase activity(GO:0016405) |
0.1 | 0.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.3 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.4 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 1.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.8 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 1.0 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.1 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) intracellular cAMP activated cation channel activity(GO:0005222) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 6.2 | GO:0004672 | protein kinase activity(GO:0004672) |
0.1 | 0.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.1 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.1 | 0.8 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.1 | 1.7 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 7.3 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.1 | 0.5 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 1.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 1.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 1.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 3.0 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 2.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 2.1 | GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors(GO:0016903) |
0.1 | 0.3 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.1 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 0.1 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.1 | 0.9 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 3.2 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.6 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 1.1 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 3.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 2.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.8 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 1.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.2 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.1 | GO:0052827 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.1 | 0.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.1 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.1 | 2.1 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.7 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 1.0 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.3 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 11.0 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.2 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.2 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.2 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 0.4 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.3 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 0.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 1.1 | GO:0015108 | chloride transmembrane transporter activity(GO:0015108) |
0.1 | 0.9 | GO:0005244 | voltage-gated ion channel activity(GO:0005244) voltage-gated channel activity(GO:0022832) |
0.1 | 0.1 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
0.1 | 0.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 2.6 | GO:0019902 | phosphatase binding(GO:0019902) |
0.1 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.2 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.1 | 0.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.1 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.0 | 1.6 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.0 | 0.6 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 1.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.0 | 0.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.6 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.5 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 2.2 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.5 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.1 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.3 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.0 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.1 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 0.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 11.3 | GO:0042802 | identical protein binding(GO:0042802) |
0.0 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 1.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.4 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 0.0 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.1 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.0 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.0 | 0.2 | GO:0022842 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.2 | GO:0016853 | isomerase activity(GO:0016853) |
0.0 | 0.0 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.0 | GO:0034543 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.0 | 0.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 2.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.1 | 1.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
1.0 | 11.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.0 | 13.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.9 | 14.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.9 | 14.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.9 | 14.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.9 | 21.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.9 | 3.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.8 | 1.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.8 | 9.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.8 | 11.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.8 | 0.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.8 | 3.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.8 | 11.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.7 | 2.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.7 | 4.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.7 | 9.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.7 | 2.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.7 | 1.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.7 | 9.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.6 | 18.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.6 | 1.9 | PID IFNG PATHWAY | IFN-gamma pathway |
0.6 | 31.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.6 | 9.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.6 | 11.3 | PID ATM PATHWAY | ATM pathway |
0.6 | 12.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.6 | 11.7 | PID REELIN PATHWAY | Reelin signaling pathway |
0.6 | 10.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.5 | 20.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.5 | 3.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.5 | 9.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.5 | 5.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.5 | 4.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.5 | 10.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.5 | 3.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.5 | 3.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.5 | 13.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.5 | 3.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 5.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.5 | 13.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.5 | 5.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.5 | 3.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.5 | 1.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 12.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.5 | 3.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 0.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.5 | 14.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.5 | 4.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.5 | 7.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.5 | 14.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.5 | 6.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.5 | 8.3 | PID MYC PATHWAY | C-MYC pathway |
0.5 | 12.0 | PID FOXO PATHWAY | FoxO family signaling |
0.5 | 1.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.5 | 9.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.5 | 1.8 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.4 | 9.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.4 | 4.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 2.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.4 | 10.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.4 | 2.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.4 | 14.0 | PID BMP PATHWAY | BMP receptor signaling |
0.4 | 2.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.4 | 10.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.4 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 2.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 3.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 12.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.4 | 1.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.4 | 4.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.4 | 9.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.4 | 2.6 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.4 | 2.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.4 | 6.1 | PID ATR PATHWAY | ATR signaling pathway |
0.4 | 9.7 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.4 | 5.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.3 | 3.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 1.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 1.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 11.2 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 10.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 3.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 1.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 4.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 0.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.3 | 3.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 0.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.3 | 0.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.3 | 0.8 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 5.6 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 4.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 2.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 4.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 8.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 3.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 0.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 3.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 4.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 7.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 1.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 2.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 6.2 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 4.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 0.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 2.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 3.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 1.5 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 3.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 2.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 2.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 0.9 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 2.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 1.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 4.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 0.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 1.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 8.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 3.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 17.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 2.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 1.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.1 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 1.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 1.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 5.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 10.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 1.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 8.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 6.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 2.6 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
1.3 | 13.4 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
1.2 | 13.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
1.2 | 13.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.2 | 12.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
1.2 | 1.2 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
1.2 | 13.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
1.2 | 14.1 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
1.2 | 5.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.2 | 12.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.2 | 17.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.1 | 21.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
1.1 | 3.3 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
1.1 | 20.5 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
1.1 | 1.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
1.1 | 9.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.0 | 1.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
1.0 | 1.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.0 | 13.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
1.0 | 5.8 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
1.0 | 19.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.9 | 18.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.9 | 5.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.8 | 7.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.8 | 5.0 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.8 | 4.9 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.8 | 11.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.8 | 4.0 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.8 | 2.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.8 | 15.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.8 | 19.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.8 | 15.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.8 | 1.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.8 | 9.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.8 | 7.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.8 | 13.1 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.8 | 11.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.8 | 13.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.8 | 0.8 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.7 | 12.7 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.7 | 8.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.7 | 19.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.7 | 7.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.7 | 14.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.7 | 29.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.7 | 22.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.7 | 4.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.7 | 8.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.7 | 0.7 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.7 | 0.7 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.7 | 7.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.7 | 6.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.6 | 5.8 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.6 | 7.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.6 | 7.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.6 | 12.5 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.6 | 6.9 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.6 | 1.2 | REACTOME KINESINS | Genes involved in Kinesins |
0.6 | 7.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.6 | 1.2 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.6 | 5.6 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.6 | 8.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.6 | 3.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.6 | 12.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.6 | 3.6 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.6 | 6.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.6 | 3.6 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.6 | 2.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.6 | 11.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.6 | 1.2 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.6 | 4.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.6 | 23.3 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.6 | 6.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.6 | 33.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.6 | 1.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.6 | 2.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.6 | 5.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.6 | 10.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.6 | 7.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.6 | 10.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.6 | 1.1 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.6 | 27.6 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.6 | 6.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.5 | 13.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.5 | 3.8 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.5 | 8.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.5 | 28.8 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.5 | 10.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.5 | 4.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.5 | 4.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.5 | 4.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.5 | 3.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.5 | 4.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.5 | 8.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.5 | 5.6 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.5 | 2.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.5 | 3.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.5 | 9.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.5 | 5.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.5 | 14.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.5 | 5.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.5 | 4.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.5 | 8.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.5 | 3.8 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.5 | 3.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.5 | 4.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.5 | 5.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.5 | 1.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.5 | 9.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.5 | 4.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.5 | 9.2 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.5 | 1.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.5 | 2.7 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.5 | 11.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.4 | 5.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 5.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.4 | 16.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.4 | 2.2 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.4 | 7.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.4 | 0.4 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.4 | 15.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.4 | 1.7 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.4 | 3.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.4 | 2.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.4 | 0.4 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.4 | 4.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 0.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.4 | 0.8 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.4 | 5.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.4 | 2.1 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.4 | 4.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.4 | 1.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.4 | 6.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.4 | 1.9 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.4 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.4 | 1.5 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.4 | 3.8 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.4 | 1.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.4 | 15.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.4 | 6.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.4 | 44.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.4 | 18.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.4 | 4.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.4 | 24.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 2.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.4 | 13.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.4 | 1.8 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.4 | 6.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.3 | 3.8 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.3 | 2.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 4.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 10.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.3 | 7.7 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.3 | 7.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 1.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 1.9 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.3 | 1.6 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.3 | 5.2 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.3 | 8.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 3.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 1.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.3 | 11.4 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.3 | 2.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.3 | 2.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 1.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.3 | 2.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 3.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 1.8 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.3 | 0.9 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.3 | 5.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 6.0 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.3 | 2.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.3 | 2.8 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.3 | 5.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 0.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.3 | 1.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.3 | 3.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.3 | 4.4 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.3 | 0.3 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.3 | 1.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.3 | 0.3 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.3 | 1.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.3 | 7.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.3 | 4.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.3 | 5.0 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.3 | 2.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 3.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 1.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 0.8 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.3 | 0.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 4.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 2.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 6.5 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.2 | 1.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 3.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.2 | 1.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 2.0 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 0.4 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 3.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 2.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 1.5 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.2 | 1.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 1.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 0.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 4.3 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.2 | 1.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 2.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 2.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 3.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 2.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 0.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.2 | 1.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 0.9 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.2 | 0.3 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 1.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 1.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 1.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.2 | 0.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 6.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 1.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 0.2 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.1 | 1.1 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.7 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.1 | 1.6 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.8 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 1.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 2.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.9 | REACTOME MEMBRANE TRAFFICKING | Genes involved in Membrane Trafficking |
0.1 | 0.8 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 5.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 11.4 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 1.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 9.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.2 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.1 | 0.5 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.1 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 4.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 6.9 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 1.7 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 0.7 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 5.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 1.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.1 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
0.1 | 2.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.1 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 0.5 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.1 | REACTOME SIGNALLING TO ERKS | Genes involved in Signalling to ERKs |
0.1 | 3.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 0.4 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 0.7 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 1.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.1 | REACTOME NEUROTRANSMITTER RECEPTOR BINDING AND DOWNSTREAM TRANSMISSION IN THE POSTSYNAPTIC CELL | Genes involved in Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell |
0.0 | 0.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.1 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 2.4 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.1 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.0 | 0.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |